Document:

Exhibit 10.77

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

MEDICARE PART B PHARMACY AND MEDICAL SUPPLIES

PROVIDER AND SERVICES AGREEMENT

THIS MEDICARE PART B PHARMACY AND MEDICAL SUPPLIES PROVIDER AND SERVICES AGREEMENT (the
“Agreement”) is entered into as of this 11th day of December, 2008 (the “Effective Date”) by and
between Express Scripts, Inc. (“ESI”), having a principal place of business at One Express Way, St.
Louis, Missouri 63121 and United States Pharmaceutical Group, LLC dba NationsHealth (collectively,
“NationsHealth”), having a principal place of business at 13630 NW 8th Street, Suite
210, Sunrise, FL 33325.

RECITALS

WHEREAS, ESI administers Medicare Part B Sponsor Programs for its Plan Sponsors (as defined in
Section 1.19 and 1.24 of this Agreement, respectively), which programs include claims
administration and other pharmacy benefit management services; and

WHEREAS, in order to fulfill its service obligation to its Plan Sponsors, ESI maintains a
variety of services relating to the delivery of pharmacy benefits and prescription services; and

WHEREAS, ESI desires to offer to its Plan Sponsors certain Medicare Part B (as defined in
Section 1.15) services, including coordination of care, fulfillment and reimbursement services, for
specific Medicare Part B Program Drugs and/or Supplies (as defined in Section 1.17); and

WHEREAS, NationsHealth performs, among other things, some of the Medicare Part B services that
ESI desires to provide to its Plan Sponsors; and

WHEREAS, ESI desires for NationsHealth to provide to ESI, and NationsHealth desires to provide
to ESI, the Medicare Part B services required by ESI as set forth in this Agreement.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, ESI and NationsHealth hereby agree as follows:

TERMS AND CONDITIONS

1. DEFINITIONS. As used in this Agreement, each of the following terms (and the plural
thereof, when appropriate) shall have the meaning set forth herein, except where the context makes
it clear that such meaning is not intended:

1.1 “Affiliate” means, as to either party: (a) any division of a party other than the
division(s) with direct responsibility for carrying out the party’s obligations under this
Agreement, and (b) any corporation or other entity which, directly or indirectly, through one or
more intermediaries, controls (i.e., possesses, directly or indirectly, the power to direct or
cause the direction of the management and policies of an entity, whether through ownership of
voting securities, by contract, or otherwise), is controlled by, or is under common control with
such party.

1.2 “Business Day(s)” means all days except national holidays observed by NationsHealth in the
ordinary course of its business. All references to “day(s)” are to calendar days unless Business
Day(s) is specified.

1.3 “CMS” means the Centers for Medicare and Medicaid Services or any successor agency with
the authority to administer the Medicare Part B program.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

 

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

1.4 “Copayment/Coinsurance” means that portion of the total charge for each prescription drug
or supply, including Medicare Part B Program Drugs and/or Supplies, that an Eligible Member is
required to pay to NationsHealth or to the NationsHealth Pharmacies pursuant to such individual’s
coverage under Medicare Part B and such individual’s Medicare Part B Sponsor Program and the
provisions of Section 3.6 of this Agreement.

1.5 “DAW Code” means the “dispense as written” codes as developed by the NCPDP, as it may be
revised from time to time.

1.6 “Deductible” means the specified dollar amount that an Eligible Member must pay each
calendar or contract year before Medicare Part B begins to make payments on eligible Medicare Part
B Program Drugs and/or Supplies.

1.7 “Disclosing Party” means that party that discloses Confidential Information to the
Receiving Party (as defined in Section 1.29) as further described in Section 8 of this Agreement.

1.8 “Electronic Channel” shall have the meaning ascribed to it in Section 6.3 of this
Agreement.

1.9 “Eligibility Files” shall have the meaning ascribed to it in Section 3.3(a) of this
Agreement.

1.10 “Eligible Member” means an individual eligible to receive prescription benefit management
services under the terms of an agreement entered into by that individual’s Plan Sponsor and ESI,
who is eligible to receive services under Medicare Part B and who is eligible to receive services
under such individual’s Medicare Part B Sponsor Program.

1.11 “EOB” means explanation of benefits received from CMS or other third party payor.

1.12 “ESI Medicare Part B Program” means the Medicare Part B program offered to Plan Sponsors
by ESI, including certain services such as fulfillment, other payor source coordination, reporting
and reimbursement coordination services.

1.13 “ESI Member” means any individual, including an Eligible Member, that was introduced to
NationsHealth by or through ESI or a Plan Sponsor, that utilizes NationsHealth for the provision of
Services (as defined in Section 1.30) hereunder to which NationsHealth has not dispensed any drugs
or supplies in the immediately preceding [* * *] period prior to the date on which NationsHealth
receives: an Eligibility File containing such individual’s name and other identifying information
from ESI; a Prescription Request or Supply Order from ESI or identifying information from an
Eligible Member or any other source, such as the Eligible Member’s name, a Prescription Request or
Supply Order.

1.14 “Identification Card” means the printed identification card issued to or obtained online
by the Eligible Member pursuant to the applicable Medicare Part B Sponsor Program.

1.15 “Medicare Part B” means the optional government health insurance program for the aged and
some disabled persons, which covers doctors’ services, outpatient hospital care, and other medical
services that are medically necessary, and in some cases preventative, which Medicare Part A
does not cover.

1.16 “Medicare Part B Program Drug(s)” means the drugs set forth in Exhibit B,
attached hereto and incorporated herein by this reference, which are reimbursable by CMS under
Medicare Part B and provided to Eligible Members under the Medicare Part B Sponsor Program. ESI and
NationsHealth may mutually agree in writing to modify, amend, delete or add to the Medicare Part B
Program Drugs list set forth in Exhibit B.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

2

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

1.17 “Medicare Part B Program Drugs and/or Supplies” means Medicare Part B Program Drugs
and/or Medicare Part B Program Supplies.

1.18 “Medicare Part B Program Supplies” means the supplies, including blood glucose monitoring
systems and other durable medical equipment set forth in Exhibit B, which are reimbursable
by CMS under Medicare Part B and provided to Eligible Members under the Medicare Part B Sponsor
Program. ESI and NationsHealth may mutually agree in writing to modify, amend, delete or add to the
Medicare Part B Program Supplies list set forth in Exhibit B.

1.19 “Medicare Part B Sponsor Program(s)” means any group or individual plan, policy,
agreement or other arrangement sponsored or issued by a Plan Sponsor and administered by ESI
pursuant to an agreement between the Sponsor and ESI, which includes pharmacy services and supplies
or benefits related to utilization of Medicare Part B Program Drugs and/or Supplies under Medicare
Part B provided to Eligible Members.

1.20 “Medicare Part D” means the voluntary federal program to subsidize the costs of
prescription drugs for Medicare beneficiaries, enacted as part of the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003, 42 C.F.R. § 423.1 et seq. (the “MMA”), as further
described in the MMA and any and all rules, regulations and official guidance promulgated by CMS in
the implementation of the Act and the prescription drug benefit.

1.21 “NCPDP” means the National Council for Prescription Drug Programs.

1.22 “NationsHealth Pharmacy” means a pharmacy or other Medicare Part B provider listed on
Exhibit C, attached hereto and incorporated herein by this reference, that provides the
Medicare Part B Program Drugs and/or Supplies set forth in Exhibit B, which is owned by
NationsHealth, operating under a name and logo owned by NationsHealth, and located in a state whose
rules and statutes allow for the implementation of this Agreement. The NationsHealth Pharmacy(ies)
also operates as an intake and dispensing center for Medicare Part B Program Supplies.

1.23 “Operation Guide” means the written guide containing the interface specifications and
describing the practices, rules, operational requirements and policies and procedures established
by ESI for the ESI Medicare Part B Program, necessary for the implementation of the Services
provided hereunder, which is more fully described in Section 6. [* * *]

1.24 “Plan Sponsor” means any health maintenance organization (HMO), insurance company,
employer or other organization having some financial responsibility for the payment of Medicare
Part B Program Drugs and/or Supplies provided to Eligible Members under a Medicare Part B Sponsor
Program and Medicare Part B for which ESI has directly or indirectly agreed to provide pharmacy
benefit management and related services, and which is designated by ESI, in its sole discretion,
for inclusion in the ESI Medicare Part B Program under this Agreement.

1.25 “Plan Sponsor Formulary” means the list of Medicare Part B Program Drugs and/or Supplies
for which a Plan Sponsor provides secondary coverage under its Medicare Part B Sponsor Program, if
such list does not include all Medicare Part B Program Drugs and/or Supplies.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

3

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

1.26 “Prescription Request” means a request to fill a prescription that is for a Medicare Part
B Program Drug that may be eligible for reimbursement under Medicare Part B and/or a Medicare Part
B Sponsor Program.

1.27 “Provider Certification” means the information form set forth in Exhibit D,
attached hereto and incorporated herein by this reference, and completed by NationsHealth (and each
of the NationsHealth Pharmacies) prior to the Effective Date of this Agreement and updated by
NationsHealth (and the NationsHealth Pharmacies, as applicable) as information therein changes as
more specifically described in Section 3.1(d) of this Agreement.

1.28 “Provider Manual” shall mean the written handbook describing the practices, rules,
operational requirements and policies and procedures established by ESI for its providers,
including regarding their provision of services to Eligible Members. It shall be NationsHealth’s
responsibility to check for any updates to the Provider Manual. The Provider Manual may be revised
from time to time by ESI in its sole discretion. ESI’s Provider Manual may be obtained at:
https://pharmacy.express-scripts.com/esi_pharmacy/portal_index.

1.29 “Receiving Party” means the party that receives Confidential Information from the
Disclosing Party as further described in Section 8 of this Agreement.

1.30 “Services” means the services provided by NationsHealth as set forth in Section 3 of this
Agreement and further described in the Operation Guide.

1.31 “Supply Order” means an order that is for Medicare Part B Program Supplies that may be
eligible for reimbursement under Medicare Part B and/or a Medicare Part B Sponsor Program.

1.32 [* * *]

2. RESPONSIBILITIES OF ESI.

2.1 Informing Plan Sponsors. ESI may inform those Plan Sponsors, which ESI determines
would benefit from utilizing ESI’s Medicare Part B Program, that it utilizes NationsHealth to
provide Medicare Part B services under the ESI Medicare Part B Program. For purposes of this
Section 2.1, the term “inform” may include the following activities: (a) [* * *]

2.2 Additional Services Provided by ESI. ESI shall be responsible for providing the
following to NationsHealth:

[* * *]

2.3 Formulary Oversight. [* * *]

3. SERVICES PROVIDED BY AND RESPONSIBILITIES OF NATIONSHEALTH.

3.1 Generally; Covered Product List and Competitive Bidding; Regulatory Compliance;
Credentialing and Recredentialing.

(a) Generally. NationsHealth shall provide to ESI the Services described and set
forth in Section 3 of this Agreement, which are necessary for ESI to implement the ESI Medicare
Part B Program. Such Services shall be provided in accordance with the specifications, conditions
and time periods set forth in this Agreement, including in the Exhibits appended hereto and in a
professional manner in compliance with the highest industry standards, care, skill, and diligence.
Accordingly, NationsHealth shall, and shall cause the NationsHealth Pharmacies to, provide

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

4

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

Services
hereunder, including the dispensing of Medicare Part B Program Drugs and/or Supplies: (i) under the
supervision of a licensed pharmacist (in the case of Medicare Part B Program Drugs); (ii) in
accordance with all applicable laws, rules and regulations; (iii) in accordance
with the applicable Medicare Part B Sponsor Program and Plan Sponsor Requirements, if any;
(iv) in accordance with ESI’s on-line messaging that such NationsHealth Pharmacy receives from ESI;
and (v) in accordance with this Agreement, the Provider Manual, the Operation Guide, any applicable
quality assurance program(s), and any ESI policy and procedure. Without limiting the generality of
the foregoing, NationsHealth shall, and shall cause the NationsHealth Pharmacies and its and their
employees, independent contractors and agents who perform Services hereunder, to perform such
Services in accordance with the highest professional standards prevailing in the community at the
time such Services are rendered, not engage in any conduct that would jeopardize the health,
welfare or safety of any Eligible Member, and at all times use and employ such individual’s best
efforts and skills, and exercise such individual’s professional judgment in the rendering of
Services hereunder. In furtherance of the foregoing, ESI shall have no responsibility for
determining the suitability of any Medicare Part B Program Drug and/or Supply for use by any
Eligible Member, including, without limitation, any drug-allergy, drug-drug or other adverse drug
reaction likelihood or possibility, all of which responsibility will be retained and discharged
solely by NationsHealth. [* * *] NationsHealth shall obtain the information from ESI by accessing
ESI’s online claims adjudication system and Eligibility Files. The parties agree to develop a
mutually acceptable process for accessing such information. The relationship between NationsHealth
and any Eligible Member is that of medical equipment and/or pharmaceutical provider and patient.
Nothing in this Agreement shall be construed to require NationsHealth to provide any Services if,
in NationsHealth’s professional judgment, such Service should not be provided. Notwithstanding the
provisions of Section 3.10 (Non-Discrimination), nothing in this Agreement shall limit
NationsHealth pharmacists’ right to communicate freely with Eligible Members, including the right
to inform Eligible Members of Services which the NationsHealth pharmacist believes are appropriate
or necessary and are included in the scope of this Agreement.

(b) Covered Product List and Competitive Bidding. [* * *]

(c) Regulatory Compliance. NationsHealth shall be responsible for ensuring CMS
regulatory compliance as it pertains to the Services it provides hereunder.

(d) Credentialing and Recredentialing.

(1) Generally. NationsHealth and the NationsHealth Pharmacies shall be eligible to
provide services hereunder, including dispensing Covered Medications, only upon satisfaction of any
credentialing and/or recredentialing and additional requirements imposed by ESI, including, subject
to subsection 3.1(d)(2), the prompt completion of, and the provision of prompt written notice with
any updates to, the Provider Certification.

(2) Delegation. NationsHealth shall cause a representative of each NationsHealth
Pharmacy to complete and return to NationsHealth, who will promptly return to ESI, all
credentialing and recredentialing materials required by ESI from time to time, including the
provider Certification set forth in Exhibit D. [* * *] Notwithstanding any of the
foregoing, NationsHealth shall maintain such credentialing/recredentialing information in a readily
retrievable format. Subject to all other conditions of acceptance, the parties acknowledge and
agree that no NationsHealth Pharmacy shall be able to participate in any ESI network until such
Provider Certification form or Exhibit E, as applicable, is received, accepted and approved
by ESI. NationsHealth shall be required to obtain up-to-date information on each NationsHealth
Pharmacy and must update the Provider Certification [* * *] by: (i) requesting that each
NationsHealth Pharmacy complete a new Provider Certification and remit the same to NationsHealth,
who will forward the same to ESI; [* * *]. Notwithstanding the immediately preceding sentence, in
the event there is any change to the information contained in the Provider Certification relating
to NationsHealth or any NationsHealth Pharmacy, NationsHealth shall provide prompt written notice
of such change(s) to ESI. [* * *] In the event NationsHealth is responsible for maintaining
credentialing and recredentialing information, including the Provider Certifications or the
information contained therein, NationsHealth acknowledges and agrees to provide a copy of the same
to ESI [* * *] of any request made by ESI.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

5

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

(3) New Pharmacy Locations Added. Notwithstanding the foregoing, as new NationsHealth
Pharmacies are added to NationsHealth (vis-à-vis, an updated Exhibit C), the parties
acknowledge and agree that a location shall not be considered participating under this Agreement
until ESI has received written notice in substantially the same form as the notice set forth in
Exhibit F, attached hereto and incorporated herein by this reference, from NationsHealth
that a new location has been added, it has received the NationsHealth Pharmacy’s Provider
Certification (or the equivalent information) and the representations and warranties in Exhibit
E are applicable to such new location and ESI has accepted and approved such NationsHealth
Pharmacy for participation.

(4) Failure to Comply. In the event NationsHealth fails to promptly complete or at
any time provide prompt updated information to the Provider Certification or fails to comply with
any other credentialing/recredentialing requirements required by ESI from time to time, such
failure shall constitute a breach of this Agreement and ESI may terminate NationsHealth or any
NationsHealth Pharmacy in accordance with the provisions of Section 5.2(b) of this Agreement. For
purposes of this Section 3.1(d), “prompt” and “promptly” shall mean: (i) with respect to initial
credentialing, prior to the Effective Date of this Agreement; and (ii) with respect to
recredentialing or any notification that information has changed, within [* * *] of the request
for recredentialing or any change in information.

3.2 Receipt and Verification of Prescription Request or Supply Order. Subject to the
verification of eligibility as described in Section 3.3, [* * *]. NationsHealth further agrees
that: [* * *] and (iii) it shall be solely responsible for the accuracy of any such prescription or
supply authorization and the dispensing thereof by NationsHealth.

3.3 Verification of Coverage and Eligibility; Determination of Coverage Under Medicare
Part B.

(a) Eligibility Files and Initial Eligibility Check. ESI shall provide to
NationsHealth Plan Sponsor eligibility files as set forth in greater detail in the Operation Guide
(the “Eligibility Files”). [* * *]

(b) Determination of Coverage under Medicare Part B. Subject to the provisions of
Section 3.3(a), upon receipt of a Prescription Request or Supply Order, or a call or other contact
from an Eligible Member, NationsHealth shall require each Eligible Member requesting Medicare Part
B Program Drugs and/or Supplies to present the information on such individual’s Identification
Card. The NationsHealth Pharmacy shall take such other reasonable steps to determine that the
presenter of the information on the Eligible Member’s Identification Card is: (i) the Eligible
Member or such Eligible Member’s covered dependent; and (ii) check the Eligibility Files to
determine that such individual is eligible for benefits under Medicare Part B. [* * *]

3.4 Dispensing; When Additional Information is Necessary; Commingling of Medicare Part B
and Medicare Part D and Plan Sponsor Formulary Deviations; Special Handling; Education
Outreach.

(a) Dispensing. Upon receipt of a Prescription Request or Supply Order, NationsHealth
shall have [* * *] to process and dispense such Prescription Request and/or Supply Order.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

6

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

(b) Additional Information Necessary To Complete A Request. In the event
NationsHealth requires additional information necessary to complete the Prescription Request and/or
Supply Order, it shall request the information needed from the appropriate individual or entity.

(c) [* * *]

(d) Special Handling and Delivery. NationsHealth agrees and acknowledges that the
delivery of Medicare Part B Drugs and/or Supplies may require special handling, e.g. refrigeration,
oversized shipping, etc. NationsHealth shall use its best efforts to adhere to any such special
handling instructions and/or requirements. NationsHealth shall ensure delivery of each dispensed
Prescription Request and Supply Order and will track the delivery thereof to the Eligible Member in
accordance with all applicable laws, rules and regulations, including the Medicare Part B rules and
regulations. NationsHealth acknowledges and agrees that Plan Sponsors may have preferences for
shipping carriers used by NationsHealth (i.e., use or
non-use of a specific carrier) to deliver Prescription Requests and Supply Orders and shall
abide by such preferences, which shall be communicated to NationsHealth by ESI as applicable.

(e) [* * *]

3.5 Claims Submission and Processing When Secondary Coverage; Coordination of
Benefits.

(a) Generally. Subject to the coordination of benefits requirements contained in
Section 3.5(b) of this Agreement, NationsHealth agrees that it shall not, and shall cause the
NationsHealth Pharmacies to not, submit a claim to ESI until it has preliminarily determined that
the individual requesting the Medicare Part B Program Drugs and/or Supplies is eligible for
Medicare Part B benefits, is eligible for benefits under the Medicare Part B Sponsor Program and
that the Prescription Request or Supply Order presented is valid and issued in accordance with
applicable laws, rules and regulations and accepted and verified by NationsHealth as described in
Section 3.2 of this Agreement. ESI shall have the right to reverse any claim submitted by
NationsHealth and offset such amount owed against any amount owing to NationsHealth by ESI for any
claim improperly submitted by NationsHealth wherein NationsHealth or the NationsHealth Pharmacy
failed to correctly check an individual’s eligibility for Medicare Part B benefits under the
Medicare Part B Sponsor Program or verify that the Prescription Request or Supply Order was issued
in accordance with applicable laws, rules and regulations as described in Section 3.2 of this
Agreement.

(b) Submission and Coordination of Benefits. Subject to the requirements of Section
3.6 of this Agreement, claims shall be submitted only for Eligible Members in accordance with the
remainder of this Subsection 3.5(b), the Provider Manual and the Operation Guide. NationsHealth
shall, and shall cause the NationsHealth Pharmacies to, [* * *] Claims submission shall include
the specific information set forth in the Provider Manual and any additional information required
by ESI necessary for ESI to process the claim. If a claim cannot be transmitted [* * *] as set
forth in the Provider Manual for any reason, the NationsHealth Pharmacy shall make reasonable
attempts to retransmit the claim. If such retransmissions fail, the NationsHealth Pharmacy shall
follow the procedures for transmission failures contained in the Provider Manual. NationsHealth
shall provide to ESI, at a minimum, all Prescription Request and/or Supply Order and reimbursement
information necessary for ESI to adjudicate the secondary coverage. Once known by ESI, ESI will
notify NationsHealth of the amount of secondary coverage payable by Plan Sponsor and will remit
such amount to NationsHealth in accordance with the provisions set forth in Exhibit G of
this Agreement. [* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

7

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

(c) Reversals for Returns. Any claims that were approved for payment by ESI and then
returned by the Eligible Member, in whole or in part, shall be reported to ESI [* * *]. Unless a
shorter time period is required by a Plan Sponsor or law (and then in accordance with such Plan
Sponsor’s requirements or the law), NationsHealth shall process returns received on a [* * *] basis
and reconcile such returns within [* * *] of the return received date. NationsHealth will submit a
reconciliation report along with a refund check for the returned claims which were paid by ESI
within [* * *] of the return received date. In the event NationsHealth fails to remit the refund
check to ESI or there is a discrepancy regarding the amount due to ESI, ESI may offset such amounts
owed to ESI against amounts owed or owing to NationsHealth.

(d) Cooperation. NationsHealth shall, and shall cause the NationsHealth Pharmacies
to, cooperate with ESI and to provide any information reasonably requested by ESI in order to
verify any information submitted with a claim necessary to pay the claim.

3.6 Collection of Deductibles, Copayments and Shipping Charges; Reimbursement from
Medicare Part B Carrier; Member Hold-Harmless; Violation.

(a) Deductibles and Copayments; Shipping Charges. NationsHealth shall, and shall
cause the NationsHealth Pharmacies to, use its best efforts to collect from each Eligible Member:
(i) such individual’s Deductible, if applicable, as indicated by the individual’s Medicare Part B
carrier; and (ii) the applicable Copayment indicated by ESI [* * *] as a result of the submission
by NationsHealth of the coordination of benefit claim, in accordance with the Provider Manual.
Deductibles and Copayments may not be waived or discounted except as permitted by law. Unless
directed by ESI in writing and in accordance with applicable law, NationsHealth shall not collect
any greater amount or any other taxes, fees, surcharges or compensation from any Eligible Member
for any Medicare Part B Program Drugs and/or Supplies or related services provided in connection
therewith. [* * *] In no event will ESI be liable for any Deductible, Copayment or shipping
charges, unless such Deductible, Copayment or shipping charge is covered by the Plan Sponsor as a
result of the coordination of benefits.

(b) Reimbursement from Medicare Part B Carrier. NationsHealth shall use its best
efforts to seek reimbursement from the appropriate Medicare Part B carrier (the “Carrier”) for such
Medicare Part B Program Drugs and/or Supplies dispensed by NationsHealth under this Agreement.
Consequently, NationsHealth shall submit primary claims to the Carrier within [* * *] of dispensing
the Medicare Part B Program Drugs and/or Supplies. In connection with the Services, only after
determining that an individual is a Medicare Part B beneficiary and an Eligible Member shall
NationsHealth generate and submit a CMS 1500 form or the electronic equivalent, and any other form
necessary, to receive reimbursement from the Carrier under Medicare Part B. [* * *] NationsHealth
agrees that if a Carrier does not approve the claim because the claim submission was incomplete,
NationsHealth will resubmit the claim with the complete and/or correct information. With respect to
claims submitted to CMS for reimbursement under Medicare Part B that are appealed and therefore, go
through the Medicare claims appeal process, the parties agree to work in good faith with the
applicable Plan Sponsor so that the claim may be submitted [* * *]. Notwithstanding the foregoing,
in the event that ESI denies a claim for timely filing or any other reason, NationsHealth shall be
permitted to submit the claim to the secondary or tertiary insurance.

(c) [* * *]

(d) Violation. In the event ESI determines that NationsHealth (or any NationsHealth
Pharmacy) has violated any portion of this Section 3.6 by inappropriately collecting amounts to
which it is not entitled, then ESI shall have the right to offset such inappropriate amounts
collected against any amounts owed to NationsHealth by ESI.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

8

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

3.7 Maintenance of Shipping Log. NationsHealth shall, and shall cause the
NationsHealth Pharmacies to, maintain a shipping log (or other evidence specifically approved in
writing by ESI), which at a minimum is incompliance with CMS guidelines. The shipping log will
include entries documenting the shipment and proof of delivery of each Medicare Part B Program Drug
and/or Supply dispensed to Eligible Members. Since the Medicare Part B Program Drug(s) and/or
Supplies are mailed or shipped to the Eligible Member, NationsHealth must obtain from the delivery
carrier, and maintain verification of (if not maintained in written format, then in a format that
is readily retrievable and easily converted to written format), proof of delivery of the Medicare
Part B Program Drug(s) and/or Supplies sent to the Eligible Member. ESI shall not be liable for
payment of any claims for Medicare Part B Program Drug(s) and/or Supplies that are not properly
documented in the shipping log via delivery verification and proof of delivery as required
hereunder. ESI may reverse claims for Medicare Part B Program Drug(s) and/or Supplies not
verifiable through the shipping log (or other applicable evidence as determined by ESI in its sole
discretion) and offset any amount owing to ESI against amounts owed to NationsHealth as more
specifically set forth in Section 3.14 (Audit) of this Agreement regarding audits and in the
Provider Manual.

3.8 Consultation Services. NationsHealth shall, and shall cause the NationsHealth
Pharmacies to, provide reasonable and appropriate drug product consultation and counseling
services. Reasonable and appropriate consultation and counseling services shall include, as a
minimum, such
consultation and counseling as required by applicable federal and state laws, rules and
regulations and Medicare Part B.

3.9 [* * *]

3.10 Non-Discrimination. NationsHealth shall not, and shall cause the NationsHealth
Pharmacies to not, refuse to provide Services required under Medicare Part B or any Medicare Part B
Sponsor Program or attempt to disenroll any Eligible Member. NationsHealth agrees, and shall cause
the NationsHealth Pharmacies to agree, to render Services hereunder to Eligible Members in the same
manner and with the same standards as offered to other customers. NationsHealth shall, and shall
cause the NationsHealth Pharmacies to, not discriminate in the performance of Services hereunder
against any Eligible Member because of race, national origin, color, ancestry, sex, marital status,
sexual orientation, religion, age, medical condition, health status, disability, political
convictions, source of payment or participation in Medicare Part B or any Medicare Part B Sponsor
Program. NationsHealth agrees that the administrative and billing practices applied for products
and services that are not Medicare Part B Program Drugs and/or Supplies provided to Eligible
Members shall be no less favorable than such practices applied to other customers.

3.11 Compliance with Agreement; Laws; Licenses and Permits. NationsHealth shall, and
shall cause the NationsHealth Pharmacies and its and their personnel to, be bound by and comply
with the provisions of this Agreement and all applicable laws, rules and regulations including, but
not limited to, fraud, waste and abuse laws and applicable state boards of pharmacy and other
applicable governmental bodies’ laws, rules and regulations. NationsHealth shall obtain and
maintain in good standing, and shall cause each NationsHealth Pharmacy and pharmacist to obtain and
maintain in good standing, at all times, all required federal, state and local licenses,
certificates and permits that are necessary to allow NationsHealth, the NationsHealth Pharmacies
and pharmacists (as applicable) to dispense and/or supply Medicare Part B Program Drugs and/or
Supplies (as applicable) to Eligible Members, and any other certificates or qualifications that may
be reasonably required by ESI from time to time. NationsHealth shall notify ESI in writing
immediately in the event of any suspension, revocation, restriction, limitation or any other
disciplinary action taken against or placed on any such license, certificate or permit or any
suspension, restriction, limitation or exclusion from participation in any federal or state health
care or other government program. NationsHealth shall (and shall cause the NationsHealth
Pharmacies and pharmacists to) provide evidence of such good standing, certification and licensure
without charge to ESI, a Plan Sponsor or a designee of ESI or Plan Sponsor within five (5) days of
written request by ESI.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

9

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

3.12 Compliance.

(a) With Medicare Part B Sponsor Program and Plan Sponsor Requirements. NationsHealth
shall, and shall cause the NationsHealth Pharmacies to, comply with each Medicare Part B Sponsor
Program and the Plan Sponsor Requirements communicated to NationsHealth or NationsHealth Pharmacies
in writing from time to time, including by facsimile, electronic mail transmission, or through [* *
*]. Failure to comply may result in sanctions, up to and including, termination as otherwise set
forth in the Provider Manual. Additionally, NationsHealth agrees, and it shall cause the
NationsHealth Pharmacies to agree, that it shall not engage in any activity that would have or has
the effect of or encourages an Eligible Member to not submit a claim for Medicare Part B Program
Drugs and/or Supplies to such Eligible Member’s Plan Sponsor for coverage under the Member’s
Medicare Part B Sponsor Program, provided that the submission of claims by NationsHealth in
accordance with this Agreement shall not be deemed to violate this sentence.

(b) With ESI’s Quality Assurance Programs (e.g., UR, QA, etc.), Formularies and Provider
Manual. NationsHealth shall, and shall cause the NationsHealth Pharmacies to, cooperate with
ESI and participate in any and all utilization review, and/or quality assurance programs,
procedures, peer review, credentialing/recredentialing processes, audit systems and any complaint
resolution procedures established by ESI or required by a Plan Sponsor from time to time. Further,
NationsHealth shall, and shall cause the NationsHealth Pharmacies to, abide by, comply with and
carry out all determinations resulting from such processes or procedures.

(c) Without limiting the generality of the foregoing, NationsHealth shall, and shall cause
each NationsHealth Pharmacy to: (i) cooperate with ESI’s procedures for utilization review and
generic substitution, as set forth from time to time in the Provider Manual; (ii) comply with ESI’s
procedures for calling prescribers to facilitate generic substitution and Formulary compliance
(including Plan Sponsor Formulary compliance), and other programs established by a Plan Sponsor, as
set forth from time to time in the Provider Manual; and (iii) comply with the Provider Manual, as
may be updated and amended from time to time by ESI, in its sole discretion. NationsHealth and the
NationsHealth Pharmacies shall use best efforts to comply with the applicable Formulary when
dispensing Medicare Part B Drugs and/or Supplies to Eligible Members. Without limiting the
generality of the foregoing, in no event will NationsHealth or the NationsHealth Pharmacies attempt
to switch an Eligible Member’s prescription to a drug that is not a Formulary drug on the
applicable Formulary, except for generic substitution opportunities or where required by medical
necessity. Neither NationsHealth nor any NationsHealth Pharmacy will implement any substitution
program for Eligible Members of Medicare Part B Sponsor Program that is inconsistent with such
Medicare Part B Sponsor Program, including the applicable Formulary.

3.13 Records.

(a) Generally. NationsHealth shall, and shall cause the NationsHealth Pharmacies to,
for a period of [* * *] following the Agreement year in which Medicare Part B Drugs and/or Supplies
were provided to Eligible Members, or in accordance with applicable law, if longer, cause the
NationsHealth Pharmacies to, maintain: (i) all medical, business, financial and administrative
records, including, all books, contracts, medical records, and patient care documentation; (ii)
original Prescription Requests and Supply Orders; (iii) shipping logs (or other evidence approved
in writing by ESI as discussed in greater detail in Section 3.7); (iv) wholesaler, manufacturer and
distributor purchase records, excluding pricing; (v) prescriber information; (vi) patient profiles;
and (vii) such other records and information relating to Medicare Part B Drugs and/or Supplies
provided to Eligible Members as may be reasonably required by ESI from time to time. NationsHealth
shall maintain such records in a readily retrievable manner. The parties agree that such records
shall be treated as confidential so as to comply with Section 8 of this Agreement and all
applicable state and Federal laws regarding the confidentiality of patient records. NationsHealth
and NationsHealth Pharmacies agree that they shall not disclose by sale, or exchange, whether or
not for profit, any ESI identifiable medical, financial or administrative records or data relating
to ESI and/or its Plan Sponsor’s Eligible Members and their Prescription Requests or Supply Orders
that they obtain as a result of providing services hereunder, including the Services, without first
obtaining ESI’s written approval. Notwithstanding the foregoing and subject to Section 8
(Confidentiality), NationsHealth and NationsHealth Pharmacies shall be permitted to disclose such
information (i) to its and their attorneys, auditors or similar confidential advisors as may be
necessary for them to perform their legitimate professional duties and (ii) as may be required by
law or regulation.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

10

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

(b) Requests for Information. NationsHealth authorizes appropriate agencies,
including, but not limited to, governmental authorities, third party payors, professional review
entities and such other organizations, to release to ESI, information deemed by ESI to be necessary
to determine NationsHealth’s (or any of the NationsHealth Pharmacies’) compliance with this
Agreement, including all policies and procedures, the Operation Guide and the Provider Manual.
NationsHealth shall, or shall cause the NationsHealth Pharmacy(ies) to, provide copies of all
records requested by ESI or Plan Sponsor, or their designee, within [* * *] from the date such
request is made, or within such shorter time as may be required by applicable laws, rules or
regulations or in order to comply with any court order or other similar legal request or
requirement.

(c) Failure to Comply. In the event NationsHealth (or any NationsHealth Pharmacy)
fails to comply with the requirements of Section 3.13, ESI shall have the right to withhold
payments to NationsHealth or any NationsHealth Pharmacy, in ESI’s sole discretion, until
NationsHealth or NationsHealth Pharmacy, as the case may be, corrects such failure by fully
complying with the requirements of this Section 3.13.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

11

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

3.14 Audit.

(a) Generally. NationsHealth agrees (and shall cause the NationsHealth Pharmacies to
agree) that ESI or a third party authorized by ESI may, upon reasonable prior notice, inspect,
review, audit, and reproduce, during NationsHealth’s regular business hours and without charge to
ESI, any of NationsHealth’s (or NationsHealth Pharmacy’s, as applicable) medical, business,
financial and administrative records relating to NationsHealth’s performance under this Agreement,
[* * *] (or other evidence approved in writing by ESI); [* * *]; and such other applicable records
and information, as may be required by ESI from time to time. ESI may reproduce these records as
may be necessary for ESI to demonstrate an alleged error or noncompliance by, or overpayment to,
NationsHealth. The parties agree that all such records shall be maintained in accordance with all
applicable state and Federal laws regarding the confidentiality of patient records. If
NationsHealth or any NationsHealth Pharmacy is found to be in violation of this Agreement or any
applicable network guidelines, including the Provider Manual or the Operation Guide, NationsHealth
and/or such NationsHealth Pharmacy shall be subject to disciplinary action as determined by [* *
*]. Further, in the event any audit uncovers that NationsHealth (or NationsHealth Pharmacy) was
paid an amount in excess of the amount due to NationsHealth (or NationsHealth Pharmacy) pursuant to
and in accordance with this Agreement, ESI shall be entitled to recover any such overpayment. The
methods used to collect amounts due hereunder to ESI as a result of audit discrepancies or
unsubstantiated claims may include, but are not limited to, an offset against any amount owed to
NationsHealth or any NationsHealth Pharmacy. Accordingly, ESI shall notify NationsHealth in
writing of such audit results, including such excess payments and shall have the right to offset
against any amounts owing to NationsHealth any such amounts owing or potentially owed to ESI for
discrepant or unsubstantiated claims or other audit-related costs, including fines which may be
imposed as further described in the Provider Manual. Audit results may also be disclosed to Plan
Sponsors. NationsHealth shall have the right to dispute and appeal any final audit determination
as provided in the Provider Manual. If ESI requires additional reimbursement from NationsHealth
(e.g., not recovered by the offset), NationsHealth shall have [* * *] from the date of written
notification to reimburse ESI the excess payment amounts. [* * *]

(b) Government Auditors. To the extent required by Section 1861(v)(1)(l) of the
Social Security Act, 42 U.S.C. Section 1395x(v)(1)(l), as amended, the parties shall, upon proper
written request, allow the United States Department of Health and Human Services, the Comptroller
General of the United States and their duly authorized representatives access to the Agreement and
to books, documents and records necessary to verify the nature and extent of the costs incurred
pursuant to the Agreement at any time during the Term of the Agreement and for an additional period
of four (4) years following the last date goods are furnished under the Agreement, or such longer
period as may be required under applicable law.

(c) Failure to Comply. In the event NationsHealth fails to comply with the
requirements of this Section 3.14, ESI shall have the right to reverse and charge back all
applicable paid claims (e.g., those subject to the audit) and may, pursuant to Section 5.2(c),
immediately terminate this Agreement, in ESI’s sole discretion.

(d) No Recourse Against Eligible Members or Plan Sponsors. In the event ESI collects
from NationsHealth amounts due as a result of any audit discrepancy, NationsHealth shall not (and
shall cause the NationsHealth Pharmacies to not) seek compensation or reimbursement from, or have
any recourse against any Eligible Member or Plan Sponsor in relation to such collection.

(e) Dispute Resolution. Subject to the requirements of Section 13.15 [* * *] of this
Agreement, the obligations of NationsHealth and the procedure for dispute resolution involving any
audit shall be as set forth in the Provider Manual.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

12

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

3.15 Disaster Planning. NationsHealth agrees that it shall (and shall cause the
NationsHealth Pharmacies to) cooperate and coordinate with ESI in implementing any commercially
reasonable disaster planning efforts undertaken by ESI to ensure that Eligible Members receive
continuous care, including continued provision of prescription medications and supplies together
with Medicare Part B Drugs and/or Supplies to Eligible Members, in the event of any Force Majeure
(as described in Section 13.9 of this Agreement).

3.16 Counterfeit Reporting. [* * *]

3.17 Hours of Service. NationsHealth shall, and shall cause the NationsHealth
Pharmacies to, provide Services hereunder according to the hours of service set forth in
NationsHealth’s Provider Certification information, as may be updated from time to time by
NationsHealth with the reasonable approval of ESI.

3.18 Multiple Pharmacies. Any NationsHealth Pharmacy or other facility providing
Services hereunder shall provide Services to Eligible Members in accordance with this Agreement
unless NationsHealth and ESI otherwise agree in writing. NationsHealth shall provide ESI with
prompt written notice of any changes to NationsHealth’s Pharmacy locations, including, additions
and deletions, so that ESI may update its records; except, that, in any instance where an addition
or deletion would have a material impact on the ESI Medicare Part B Program or any Medicare Part B
Sponsor Program, as determined in ESI’s sole authority and discretion, ESI shall determine whether
such location(s) will be added or deleted under this Agreement and communicate the same to
NationsHealth in writing. In the event ESI determines that a location may not be added or deleted
hereunder due to such change materially impacting the ESI Medicare Part B Program or any Medicare
Part B Sponsor Program, NationsHealth agrees that is shall not add or delete such location (except
if such deletion is due to the sale of such location to an entity or individual that is not an
Affiliate of NationsHealth). Additionally, any right ESI has to offset amounts owing to ESI
hereunder against amounts owed to NationsHealth or any NationsHealth Pharmacy may, at ESI’s sole
discretion, be offset against amounts owed to NationsHealth or any NationsHealth Pharmacy
regardless of which location is responsible for the amount owed.

4. PAYMENT FOR MEDICARE PART B DRUGS AND/OR SUPPLIES; CHARGES; INCORRECT PAYMENTS; TAXES.

4.1 Payment to NationsHealth.

(a) Generally. For Services performed in accordance with the terms and conditions of
this Agreement, ESI shall pay NationsHealth in accordance with Exhibit G, less the
applicable Deductible and Copayment. Payment shall be based upon the information submitted for
each claim by NationsHealth to ESI in accordance with Section 3.5 of this Agreement. Unless
otherwise required by applicable law, [* * *]. Additional information, or rejected or disputed
claims must be submitted or resubmitted, as applicable, by NationsHealth within [* * *] of the
request for additional information, initial rejection or dispute. ESI may deny payment for any
claim not submitted within this time period. Further, ESI may refuse to pay any claim or may
reverse payment of any claim that is not submitted in accordance with the terms and conditions of
this Agreement. Notwithstanding the foregoing, with respect to claims submitted to CMS for
reimbursement under Medicare Part B that are appealed and therefore, go through the Medicare claims
appeal process, the parties agree to work in good faith with the applicable Plan Sponsor so that
the claim may be submitted after the expiration of the [* * *]; provided, however, NationsHealth
acknowledges and agrees that any decision to allow the claim to be processed after the expiration
of the [* * *] shall be made solely by the Plan Sponsor and there is no guarantee that the Plan
Sponsor will allow such claim to be processed; and provided further that in such case,
NationsHealth agrees to provide any additional information necessary for such claim to be a
“complete claim” within the [* * *] of the request for additional information.

(b) [* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

13

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

4.2 Incorrect Payments.

(a) Generally. Any payments made to NationsHealth (or any NationsHealth Pharmacy) in
excess of any amount properly determined to be due by ESI, if any, under this Agreement, due to an
error by either party, inaccurate claims submission or information submitted by NationsHealth (or
discovered through any audit as described in Section 3.14 (Audit) of this Agreement), may be
recovered by ESI from NationsHealth (or any individual NationsHealth Pharmacy). ESI shall notify
NationsHealth (and NationsHealth Pharmacy, if applicable) in writing of such excess payment(s) and
shall have the right to either
offset the excess payment amount as provided in Section 3.14 or require prompt reimbursement
from NationsHealth.

(b) Remittance Advices. NationsHealth acknowledges and agrees (and shall cause its
NationsHealth Pharmacy(ies) to acknowledge and agree) that it is obligated to review remittance
advices received from ESI to verify their accuracy. NationsHealth must notify ESI in writing of any
alleged error, miscalculation, or discrepancy (and a detailed basis of such allegation) whether
paid, denied, reversed or rejected, within [* * *] of the date of each remittance advice if it
disputes any information thereon as further described in the Provider Manual. Otherwise,
NationsHealth will be deemed to have confirmed the accuracy of the claims processed under such
remittance advice and waives any claim it may have for errors, miscalculations or discrepancies if
it fails to object within such period. Further and notwithstanding the foregoing, NationsHealth
acknowledges and agrees (and shall cause its NationsHealth Pharmacy(ies) to acknowledge and agree)
that it shall notify ESI in writing within [* * *]. Upon proper notice to ESI and verification of
amounts to be paid, if any, ESI shall only be responsible for remitting additional payments to a
NationsHealth in connection with the specific disputed remittance advice; except, that, if
NationsHealth has breached any provision of this Agreement with respect to such claim, ESI shall
have no obligation to reimburse NationsHealth for the claim. If NationsHealth does not notify ESI
in the manner and time provided herein, ESI shall have no further responsibility with respect to
such remittance. Notwithstanding any of the foregoing, in no event shall ESI be liable above or
beyond the appropriately applied rates, as determined by ESI, that are agreed to by the parties as
set forth in Exhibit G.

(c) Taxes. If permitted by the terms of its agreement with the Plan Sponsor, ESI will
bill the Plan Sponsor for any Federal, state, or local sales taxes payable with respect to
NationsHealth’s sales of Medicare Part B Drugs and/or Supplies to an Eligible Member, and will
remit to NationsHealth any such taxes collected from Plan Sponsors. NationsHealth shall remit, or
cause the NationsHealth Pharmacies to remit, any such sales taxes to the appropriate taxing
authority. NationsHealth or the NationsHealth Pharmacies shall be solely responsible for any other
taxes or surcharges associated with their performance under this Agreement. Applicable sales or
other tax imposed by law on the dispensing of Medicare Part B Drugs and/or Supplies to Eligible
Members not reimbursed by the Plan Sponsor or ESI or included in the Copayment/Deductible may be
pursued with the Eligible Member in accordance with applicable laws, rules and regulations, subject
to the restrictions, if any, imposed by such Eligible Member’s Plan Sponsor. In no event, including
non-payment by Plan Sponsor or any Eligible Member, will ESI be liable for any Federal, state, or
local sales taxes hereunder. For purposes of this Section 4.2(c), “sales tax” means any excise tax
on Medicare Part B Drugs and/or Supplies now or hereafter in existence required to be collected or
paid by a retail seller on consumer retail sales, whether designed as a sales tax, gross receipts
tax, retail occupation tax, value added tax, or otherwise.

4.3 Fair Market Value. Both parties acknowledge and agree that the reimbursement
provided herein represents the fair market value for the services provided by the parties
hereunder, including the provision of Services, negotiated at arms length without regard to the
volume or value of referrals or any other business between the parties.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

14

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

5. TERM AND TERMINATION.

5.1 Term. Unless earlier terminated as provided in Section 5.2 of this Agreement, the
term of this Agreement shall begin on the Effective Date and continue for a period of three (3)
years (the “Initial Term”). Thereafter, this Agreement shall automatically renew for successive
two (2) year terms (each, a “Renewal Term”) unless either party provides one hundred and eighty
(180) days prior written notice to the other party of its intent not to renew this Agreement or
this Agreement is earlier terminated as provided in Section 5.2 (the “Initial Term” and any
“Renewal Term” shall collectively be referred to herein as the “Term”).

5.2 Termination.

[* * *]

6. OPERATION GUIDE.

6.1 Generally. ESI will forward all Supply Orders and Prescription Requests in
accordance with the terms of this Agreement and the Operation Guide. NationsHealth shall
communicate via the Electronic Channel all dispensing and delivery records as well as communicate
all updates to clinical records to ESI.

6.2 Development of Operation Guide. [* * *] to develop the Operation Guide by the
Effective Date of this Agreement, but in no event later than [* * *] after the Effective Date. To
the best of ESI’s knowledge and intent, the Operation Guide shall be consistent with all applicable
laws, rules and regulations. To the extent the Operation Guide is inconsistent with any law, rule
or regulation, the specific law, rule or regulation shall prevail and ESI agrees to amend the
Operation Guide accordingly.

6.3 Guidelines for the Operation Guide. The Operation Guide shall include the
development and implementation of a secure electronic channel (“Electronic Channel”) between ESI
and NationsHealth. [* * *]

6.4 Costs and Intellectual Property Rights Relating to the Electronic Channel.
NationsHealth shall be responsible for its own costs associated with the development and
implementation necessary to perform any of its obligations under this Agreement from the point
after which a Supply Order or Prescription Request is received from ESI. Any intellectual property
created or developed by ESI to develop and establish the Electronic Channel or the connectivity
between ESI and NationsHealth’s operating systems shall be the sole property of ESI. Any
intellectual property created or developed solely by NationsHealth to develop and establish the
Electronic Channel or the connectivity between ESI and NationsHealth’s operating systems shall be
the sole property of NationsHealth. ESI shall take such actions as reasonably necessary to maintain
the Electronic Channel. The parties agree to [* * *] incurred in connection with the maintenance of
the Electronic Channel during the Term of this Agreement, [* * *].

6.5 Electronic Communication. ESI and NationsHealth agree to maintain the capability
to send, receive, or display electronic messages to and from NationsHealth or its designated agent
in accordance with HIPAA transaction standards and standards as may be established from time to
time and mutually agreed to by the parties. ESI and NationsHealth shall receive all messages
transmitted by the other party in accordance with the Operation Guide and take appropriate action
upon receipt of such messages.

7. PERFORMANCE STANDARDS.

7.1 [* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

15

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

7.2 Reserved.

7.3 Other Performance Standards. [* * *]

8. CONFIDENTIALITY.

8.1 Generally. ESI acknowledges and agrees, and NationsHealth acknowledges and
agrees, itself and on behalf of the NationsHealth Pharmacies, that in the performance of Services
hereunder, the parties will come into contact with certain confidential business and other
information regarding and belonging to the other party. “ESI Confidential Information” includes,
but is not limited to, the following: (a) the terms and conditions of this Agreement, all
information provided to NationsHealth in order for NationsHealth to provide Services to Eligible
Members (e.g., eligibility information including Eligibility Files and Eligible Member and Plan
Sponsor information, etc.) and all information disclosed to NationsHealth pursuant to negotiations
between the parties; (b) all information pertaining to ESI’s business and services, including
pricing and other financial and contractual arrangements, products, programs, services, business
practices, marketing strategies, and customer lists; (c) ESI’s manuals, policies and procedures,
including quality assurance procedures, and any other similar information provided to
NationsHealth, and all copies thereof regardless of the medium in which it is provided (e.g., paper
or electronic); (d) ESI’s information
technology, including all databases, software, applications, systems, layouts, designs,
formats, procedures, and processes; (e) information pertaining to ESI’s Plan Sponsors, any Medicare
Part B Sponsor Program, and all formularies; and (f) all ESI files, analyses, publications,
reports, edits, protocols, and any other documents, both internal and available to NationsHealth
(collectively, (a) through (f) shall be referred to herein as “ESI’s Confidential Information”).
“NationsHealth Confidential Information” includes (g) all information disclosed to ESI pursuant to
negotiations between the parties; (h) all information pertaining to NationsHealth’s business and
services, including pricing and other financial and contractual arrangements, products, programs,
services, business practices, marketing strategies, and customer lists; (i) NationsHealth’s
information technology, including all databases, software, applications, systems, layouts, designs,
formats, procedures, and processes; and (j) all NationsHealth files, analyses, publications,
reports, edits, protocols, and any other documents, both internal and available to ESI
(collectively, (g) through (j) shall be referred to herein as “NationsHealth Confidential
Information”). ESI agrees that it shall not, and NationsHealth agrees that it shall not (and shall
cause the NationsHealth Pharmacies and its and their employees, officers, directors, independent
contractors and agents to agree to not) disclose, sell, assign, transfer, give or use or enable
anyone else to disclose, sell, assign, transfer, give or use, in whole or in part, any of the other
party’s Confidential Information to any third party. Confidential Information of the other party
may be disclosed to employees, agents or contractors of a party only to the extent necessary for
such party to perform their duties and only if they undertake the obligations of confidentiality as
provided herein. Additionally, ESI may disclose Confidential Information to comply with its
contractual obligations with its Plan Sponsors. NationsHealth must (and shall cause the
NationsHealth Pharmacies to) immediately notify ESI if it becomes aware of any unauthorized use of
ESI Confidential Information. ESI shall immediately notify NationsHealth if it becomes aware of any
unauthorized use of NationsHealth Confidential Information. Each party agrees to immediately return
all of the other party’s Confidential Information to the other party upon request and/or upon
termination of this Agreement for any reason; except, that, each party may retain one (1) copy of
the other party’s Confidential Information for evidentiary purposes only.

8.2 Certain Disclosures. If the Receiving Party is requested or required (by oral
questions, interrogatories, requests for information or documents, subpoena, civil investigative
demand, any informal or formal investigation by any government or governmental agency or authority,
law or regulation, or otherwise) to disclose any of the other party’s Confidential Information, the
Receiving Party will notify the Disclosing Party promptly in writing so that the Disclosing Party
may seek a protective order or other appropriate remedy or, in its sole discretion, waive
compliance with the terms of this Agreement. The Receiving Party agrees not to oppose any action
by the Disclosing Party to

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

16

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

obtain
a protective order or other appropriate remedy. If no such
protective order or other remedy is obtained, or the Disclosing Party waives compliance with the
terms of this Agreement, the Receiving Party will furnish only that portion of the other party’s
Confidential Information which it is advised by counsel is legally required and will exercise its
reasonable best efforts to obtain reliable assurance that confidential treatment will be accorded
the other party’s Confidential Information. Either party may disclose the Agreement if required by
applicable securities laws; provided, however, that the Disclosing Party shall redact any pricing
and reimbursement-related terms; ensure that the confidential header contained in this Agreement is
placed on the copy disclosed; and notify ESI in writing prior to disclosure.

8.3 Exceptions. The “Confidential Information” of a party shall not include: (a)
information which is public or becomes public through no fault of the party having the obligation
to keep such information confidential, including the Receiving Party; (b) information which the
Receiving Party has knowledge of prior to receipt hereunder, other than under an obligation of
confidentiality, as evidenced in writing and dated prior to the Effective Date of this Agreement;
and (c) information which is received by the Receiving Party from a third person not under an
obligation of confidentiality.

8.4 HIPAA. ESI shall and NationsHealth shall, and shall cause the NationsHealth
Pharmacies to, comply with all federal and state laws, rules and regulations regarding the
confidentiality of patient information, including, but not limited to, compliance with the Health
Insurance Portability and Accountability Act of 1996 as amended, including applicable rules,
regulations and official guidance promulgated thereunder (collectively, “HIPAA”) by the U.S.
Department of Health and Human Services or otherwise. To the extent NationsHealth is determined to
be a Business Associate (as such term is defined by HIPAA) of ESI’s (or any ESI Affiliate), then
NationsHealth agrees to act in accordance with the terms of that certain Business
Associate Agreement dated as of November 30, 2007, by and between the parties, a copy of which
is attached hereto as Exhibit J and incorporated herein by this reference.

8.5 Remedies. The parties acknowledge and agree that any breach of Section 8 of this
Agreement would cause immediate and irreparable injury or loss to the non-breaching party that
cannot be fully remedied by monetary damages. Accordingly, if a party fails to abide by the terms
and conditions set forth in Section 8 of this Agreement, the non-breaching party shall be entitled
to specific performance, including immediate issuance of a temporary restraining order or
preliminary injunction enforcing the terms of this Agreement, and to judgment for damages
(including reasonable attorneys’ fees and costs) caused by the breach, and to all other legal and
equitable remedies available to such non-breaching party.

9. INSURANCE, INDEMNIFICATION AND LIABILITY.

9.1 Liability Insurance. NationsHealth shall obtain and maintain, and shall cause the
NationsHealth Pharmacies to obtain and maintain, in full force and effect and throughout the Term
of this Agreement, such policies of general liability, professional liability and other insurance
of the types and amounts as are reasonably and customarily carried by pharmacies with respect to
their operations. NationsHealth shall obtain and maintain, for itself and each NationsHealth
Pharmacy, or shall cause each NationsHealth Pharmacy to obtain and maintain during the Term of this
Agreement, comprehensive general liability insurance coverage in the amount of at least [* * *] per
occurrence and [* * *] annual aggregate per NationsHealth Pharmacy, including pharmacist’s
professional liability insurance, for protection from claims for bodily injury and personal injury
to Eligible Members from NationsHealth’s operation or the operation of the NationsHealth Pharmacies
under this Agreement. By signing this Agreement, NationsHealth represents and warrants that these
insurance requirements are being met. NationsHealth shall furnish or cause to be furnished not less
than thirty (30) days’ prior written notice to ESI in the event of termination or material
modification of any such policies of insurance. Upon ESI’s request, NationsHealth shall provide
ESI with evidence of such insurance coverage satisfactory to ESI. If the insurance purchased to
satisfy the requirements of this Section 9.1 is “claims made”, then upon termination of such
coverage, NationsHealth shall purchase an extended period of indemnity (“tail” coverage) or a
retroactive date on replacement coverage so that ESI is protected from any and all claims brought
against ESI for a period of not less than three (3) years subsequent to the date of termination of
this Agreement.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

17

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

9.2 Indemnification.

(a) [* * *]

(b) [* * *]

(c) [* * *]

10. REPRESENTATIONS AND WARRANTIES.

10.1 NationsHealth. NationsHealth represents and warrants (itself and on behalf of
the NationsHealth Pharmacies) that:

(a) It and the NationsHealth Pharmacies and all personnel (as applicable) are appropriately
licensed and have not been sanctioned or had its (or his or her) license suspended, revoked,
restricted, limited or otherwise disciplined and have not been and is currently not suspended,
restricted, limited or excluded from participating in any federal or state health care or other
government program;

(b) The answers it supplied to the questions contained in the Provider Certification are true
and accurate and NationsHealth shall notify ESI immediately in writing in the event any statement
becomes inaccurate or untrue;

(c) It has obtained liability insurance in compliance with the terms of Section 9.1 of this
Agreement;

(d) It does not have a conflict of interest which would impact its ability to perform fairly
its obligations under this Agreement, and it is not subject to any restrictions, contractual or
otherwise, which prevent or would prevent it from entering into this Agreement or carrying out its
obligations hereunder;

(e) This Agreement represents the entire agreement between the parties with respect to the
subject matter hereof, the services provided by NationsHealth are bona fide services in exchange
for fair market value payment, negotiated at arms length between the parties and that payment
herein does not take into account, and is not intended to induce or otherwise affect, any referrals
made by the parties;

(f) It has not and the NationsHealth Pharmacies have not: (i) been excluded, debarred,
suspended or declared ineligible to participate in any federal health care program, state health
care program, or any federal procurement or non-procurement program, (ii) been convicted of a
criminal offense that falls within the ambit of 42 U.S.C. § 1320a-7(a), or (iii) received notice
that any state or federal government proposes to exclude, debar or suspend it from, or declare it
ineligible to participate in, any federal health care program, state health care program or any
federal procurement or non-procurement program. NationsHealth agrees to promptly notify ESI in the
event that NationsHealth or any NationsHealth Pharmacy is excluded, debarred, suspended or declared
ineligible to participate in any federal health care program, state health care program, or any
federal procurement or non-procurement program;

(g) It is duly organized, validly existing and in good standing, and has the power to own its
property and to carry on its business as now being conducted by it;

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

18

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

(h) The execution and delivery of this Agreement and the consummation of the transactions
contemplated herein on its part, has been duly authorized by all necessary action;

(i) Neither the execution and delivery of this Agreement nor the consummation of the
transactions contemplated hereby will be a violation or default of any term or provision of
NationsHealth’s governance documents (e.g., its certificate of incorporation or bylaws or operating
agreement) or of any contract, commitment, or other agreement or restriction to which it is a party
or by which it is bound). The execution and performance of the obligations in this Agreement do not
require the consent or approval of any third party or any governmental entity or agency;

(j) It has a written Code of Conduct that, at a minimum, requires: (i) its officers,
directors, and employees to act in an ethical and legally compliant manner in performing their
duties and functions; (ii) all such officers, directors, and employees to report conduct that is in
violation of such Code of Conduct; and (iii) NationsHealth to take action to address and remedy any
such violation of its Code of Conduct, including, but not limited to, taking all appropriate
disciplinary action. NationsHealth further represents and warrants that: (iv) it will maintain
such written Code of Conduct in place throughout the entire Term of this Agreement; (v) it requires
its officers, directors and employees to acknowledge their obligation to comply with such written
Code of Conduct at least annually; and (vi) it will use its best efforts to ensure compliance with
such Code of Conduct. NationsHealth’s current Code of Conduct is attached hereto and incorporated
herein as Exhibit K, and is subject to the ESI’s confidentiality obligations hereunder.
NationsHealth will provide ESI with a copy of its then current Code of Conduct annually on or about
the anniversary date of the Effective Date. Failure to comply with this provision, in whole or in
part constitutes a material breach of this Agreement provided that failure to provide a copy of the
Code of Conduct on the anniversary date shall not constitute a material breach unless ESI has
notified NationsHealth of such failure and NationsHealth has failed to provide a copy of such
current Code of Conduct within five (5) Business Days of receiving such notification;

(k) It is not currently operating under a Corporate Integrity Agreement; and

(l) It will maintain an adequate inventory of Medicare Part B Drugs and Medicare Part B
Supplies to perform the Services contemplated hereunder.

10.2 By ESI. ESI represents and warrants that:

(a) This Agreement represents the entire agreement between the parties with respect to the
subject matter hereof, the services provided by NationsHealth are bona fide services in exchange
for fair market value payment, negotiated at arms length between the parties and that payment
herein does not take into account, and is not intended to induce or otherwise affect, any referrals
made by the parties;

(b) [* * *];

(c) [* * *];

(d) It is duly organized, validly existing and in good standing, and has the power to own its
property and to carry on its business as now being conducted by it;

(e) The execution and delivery of this Agreement and the consummation of the transactions
contemplated herein on its part, has been duly authorized by all necessary action;

(f) [* * *]; and

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

19

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

(g) It has not, [* * *]: (i) been excluded, debarred, suspended or declared ineligible to
participate in any federal health care program, state health care program, or any federal
procurement or non-procurement program, (ii) been convicted of a criminal offense that falls within
the ambit of 42 U.S.C. § 1320a-7(a), or (iii) received notice that any state or federal government
proposes to exclude, debar or suspend it from, or declare it ineligible to participate in, any
federal health care program, state health care program or any federal procurement or
non-procurement program. ESI agrees to promptly notify NationsHealth in the event that ESI is, [*
* *], excluded, debarred, suspended or declared ineligible to participate in any federal health
care program, state health care program, or any federal procurement or non-procurement program.

11. LICENSE TO USE OTHER PARTY’S NAME AND LOGO.

11.1 Grant.

(a) By ESI. ESI is the owner of all right, title and interest in and to the Mark and
Logo as further detailed in Exhibit L, attached hereto and incorporated herein by this
reference, including any and all goodwill associated therewith and symbolized thereby. To
effectuate the purpose of this Agreement, ESI as licensor hereby grants to NationsHealth as
licensee, for the Term of this Agreement, a royalty-free, non-transferable, terminable,
non-exclusive license, expressly subject to the terms and conditions of this Agreement to use the
Mark and Logo solely on and in connection with furthering the purposes of this Agreement.
NationsHealth shall have no right to sublicense, assign or transfer any of the rights granted it
hereunder.

(b) By NationsHealth. To effectuate the purpose of this Agreement, NationsHealth as
licensor hereby grants to ESI as licensee, for the Term of this Agreement, a royalty-free,
non-transferable, terminable, non-exclusive license, expressly subject to the terms and conditions
of this Agreement to use NationsHealth’s marks and logos solely on and in connection with
furthering the purposes of this Agreement. ESI shall have no right to sublicense, assign or
transfer any of the rights granted it hereunder.

11.2 Quality Control.

(a) Of The Parties. Each party recognizes that its mark and logo, including the
associated goodwill, have great value to it. Each party covenants and agrees that all uses by it of
the other party’s mark and logo shall inure solely to the benefit of the holder and that the user shall
not acquire any right, title, or interest in, to or under the mark or logo as a result of this
license and/or its use of the mark or logo under this license.

(b) By NationsHealth. Further, NationsHealth

(1) shall not intentionally do, nor shall it knowingly permit to be done, any act that may
prejudice, impair or otherwise adversely affect the Mark or Logo or the goodwill associated
therewith. NationsHealth covenants that it will not in any way challenge ESI’s ownership of the
Mark or Logo or the validity of the registration of the Mark or Logo.

(2) covenants and agrees that it shall only use the Mark and/or Logo: (i) in connection with
this Agreement, (ii) in a manner and form designed to maintain the high quality of the Mark and/or
Logo and keeping with the image, reputation and goodwill symbolized by and associated with the Mark
and/or Logo; (iii) in a form and manner that is consistent with the use of the Mark and Logo by
ESI, and as may be required by ESI, in its sole and absolute discretion; (iv) in a manner and form
that protects ESI’s ownership interest therein; and (v) in a manner and form that complies with all
applicable federal, state, local and foreign laws, rules and regulations.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

20

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

(3) agrees to assist ESI, at ESI’s request, in taking any actions ESI deems necessary to
protect the Mark and Logo and/or to confirm and/or vest ESI’s exclusive ownership, right title, and
interest in, to and under the Mark and Logo. ESI shall reimburse NationsHealth for any out of
pocket expenses incurred by NationsHealth in complying with such request.

(c) Reservation of Rights.

(1) By ESI. All rights in the Mark and/or Logo other than those specifically granted
to NationsHealth pursuant to this Agreement are expressly reserved by ESI. Nothing in this
Agreement is intended to limit or impair ESI’s rights, during or after the Term, to protect the
Mark and/or Logo from infringement by any person or party, including, without limitation,
NationsHealth. During and after the Term, ESI may, but shall not be obligated to, take such action
as it deems necessary or appropriate to prevent or stop such infringement. NationsHealth shall
promptly notify ESI in writing of any infringement or suspected infringement involving the Mark
and/or Logo known to NationsHealth.

(2) By NationsHealth. All rights in the marks and/or logos other than those
specifically granted to ESI pursuant to this Agreement are expressly reserved by NationsHealth.
Nothing in this Agreement is intended to limit or impair NationsHealth’s rights, during or after
the Term, to protect the mark and/or logo from infringement by any person or party, including,
without limitation, ESI. During and after the Term, NationsHealth may, but shall not be obligated
to, take such action as it deems necessary or appropriate to prevent or stop such infringement.
ESI shall promptly notify NationsHealth in writing of any infringement or suspected infringement
involving the mark and/or logo known to ESI.

11.3 Termination of License.

(a) By ESI. ESI may terminate its license for NationsHealth to use the Mark and/or
Logo with or without cause, by providing NationsHealth with [* * *] written notice.

(b) By NationsHealth. NationsHealth may terminate its license for ESI to use the
NationsHealth marks and/or logos with or without cause, by providing ESI with [* * *] written
notice.

12. MEDICARE PART B REQUIREMENTS.

12.1 Generally. NationsHealth and ESI agree that ESI may delegate activities or
functions to NationsHealth only in a manner consistent with applicable laws, rules and regulations
including the Medicare Part B laws, rules and regulations, Section 8.4 and this Section 12.1:

(a) Arrangements must be in writing and must specify NationsHealth’s delegated activities and
reporting responsibilities;

(b) ESI shall, on an ongoing basis, monitor NationsHealth’s performance of Services in
accordance with this Agreement;

(c) NationsHealth agrees to comply, and require its subcontractors to comply, with all
applicable federal and state laws and regulations, including Medicare laws and regulations,
confidentiality requirements, and CMS-provided instructions and policies, as applicable to the
Services; and

(d) NationsHealth agrees to abide by state and federal privacy and security requirements
including the HIPAA privacy and security provisions pursuant to 45 C.F.R. §§ 160 and 164.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

21

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

13. MISCELLANEOUS PROVISIONS.

13.1 [* * *]

13.2 Notice. Except as otherwise provided in this Agreement, any notice required to
be given pursuant to the terms and conditions of this Agreement shall be in writing and: (a)
delivered in person, evidenced by a signed receipt; (b) deposited in the United States mail,
certified or registered, return receipt requested (or other similar method of delivery with a
nationally recognized carrier (e.g., FedEx, UPS)); (c) delivered by facsimile, evidenced by a
transmission receipt; or (d) delivered by email transmission to the email address listed below, as
evidenced by a copy of the successful email transmission displaying such email address and followed
up by hard copy sent by mail, to ESI or NationsHealth at the address set forth below or to the last
address subsequently reported in writing to the respective party:

	 	 	 	 	 
	 

	 	If to ESI:
	 	Express Scripts, Inc.
	 

	 	 	 	One Express Way
	 

	 	 	 	St. Louis, Missouri 63121
	 

	 	 	 	Attention: Sr. Vice President of Network Contracting and Management
	 

	 	 	 	[* * *]
	 
	 	 	 	 
	 

	 	With copies to:
	 	Express Scripts, Inc.
	 

	 	 	 	One Express Way
	 

	 	 	 	St. Louis, Missouri 63121
	 

	 	 	 	Attention: General Counsel and

                 Counsel for Network Contracting and Management
	 
	 	 	 	 
	 

	 	And to:
	 	Express Scripts, Inc.
	 

	 	 	 	One Express Way
	 

	 	 	 	St. Louis, Missouri 63121
	 

	 	 	 	Attention: Vice President Medicare
	 

	 	 	 	[* * *]
	 
	 

	 	If to NationsHealth:
	 	NationsHealth, Inc.
	 

	 	 	 	13630 NW 8th Street, Suite 210
	 

	 	 	 	Sunrise, FL 33325
	 

	 	 	 	Attention: Chief Executive Officer
	 

	 	 	 	[* * *]
	 
	 

	 	With copies to:
	 	NationsHealth, Inc.
	 

	 	 	 	13630 NW 8th Street, Suite 210
	 

	 	 	 	Sunrise, FL 33325
	 

	 	 	 	Attention: Legal Department
	 

	 	 	 	[* * *]
	 
	 	 	 	 
	 

	 	And to:
	 	NationsHealth, Inc.
	 

	 	 	 	13630 NW 8th Street, Suite 210
	 

	 	 	 	Sunrise, FL 33325
	 

	 	 	 	Attention: NationsHealth Project Manager for Express Scripts
	 

	 	 	 	[* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

22

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

Notice will be deemed received on (e) the date of delivery if the notice is personally delivered,
sent via certified or registered mail, return receipt requested (or other similar method of
delivery with a nationally recognized carrier), sent via facsimile or email transmission, or (f)
the third business day after the date of mailing of the notice is mailed by United States mail.
Notwithstanding the foregoing, ESI may give notices to NationsHealth (or any NationsHealth
Pharmacy) relating to particular claims, DUR messaging and similar notices typically provided to
providers generally via its on-line claims system or in any remittance advice.

13.3 Entire Agreement. This Agreement, including its Exhibits, Provider
Certification, Provider Manual, Operation Guide and any Plan Sponsor Requirements communicated to
NationsHealth constitutes the entire agreement of the parties with respect to the subject matter
hereof and, upon execution by the parties, supersedes all prior oral or written agreements between
the parties with respect to the subject matter hereof.

13.4 Amendment.

(a) Generally. Except as otherwise provided herein, no modification, alteration,
amendment or waiver of any term, covenant or condition of this Agreement shall be valid unless set
forth in writing and signed by the parties to this Agreement; except, that, ESI may amend the
Provider Manual and its policies and procedures at any time, in its sole discretion, and a Plan
Sponsor may amend its Medicare Part B Sponsor Program or its Plan Sponsor Requirements at any time,
in its sole discretion, and such amendment shall not require the consent of NationsHealth or any
NationsHealth Pharmacy.

(b) Change in Law. In the event that any law, rule or regulation is enacted,
promulgated or amended, or any interpretation of law, rule or regulation by a court or regulatory
authority of competent jurisdiction is made, after the Effective Date of this Agreement
(collectively, “Change in Law”), then ESI may amend this Agreement to comply with any such changes
required or suggested by such law, rule and/or regulation, or court or regulatory authority. ESI
shall furnish NationsHealth with written notice of such amendment(s) by giving NationsHealth [* *
*] advance written notice of the terms of such amendment. In the event any such amendment
constitutes a material change in the terms of this Agreement that is unacceptable to NationsHealth,
NationsHealth may elect to terminate this Agreement by giving written notice of such election to
terminate to ESI within [* * *] of the date of receipt of the proposed amendment, and such
termination shall be effective no earlier than [* * *] after receipt of written notice by ESI. If
NationsHealth does not elect to terminate this Agreement within [* * *] period or NationsHealth
continues to submit claims after the effective date of any amendment, then such amendment will be
deemed approved and accepted by NationsHealth as if NationsHealth had given its express written
consent thereto, and such amendment shall automatically become a part of this Agreement. In the
event that ESI does not amend this Agreement as contemplated above, NationsHealth may request an
amendment to this Agreement to comply with any Change in Law. ESI shall consider any such
requested amendment and negotiate with NationsHealth in
good faith regarding such amendment. ESI acknowledges and agrees that NationsHealth shall not
be in breach of this Agreement if it is unable to strictly comply with the provisions hereof due to
a Change in Law provided that NationsHealth complies as closely as possible with this Agreement
within the constraints of such Change in Law.

13.5 Relationship of the Parties. In the performance of this Agreement, it is
mutually understood and agreed to that the relationship created hereunder is that of independent
contractors and nothing herein is intended or shall be construed to create or be deemed to create
an employer/employee relationship, agency, partnership or joint venture relationship, or any other
legal relationship between the parties other than that of independent contractors. Further,
NationsHealth shall not be considered a client of ESI. No provision of this Agreement or any part
of any Plan Sponsor’s Medicare Part B Sponsor Program shall be construed to require any pharmacist
to dispense any Medicare Part B Drug and/or Supply to any Eligible Member if, in the pharmacist’s
reasonable professional judgment, such Medicare Part B Drug and/or Supply should not be dispensed
to such Eligible Member. In such event, NationsHealth agrees to notify ESI in writing of the
circumstances of the decision not to dispense such Medicare Part B Drug and/or Supplies to the
applicable Eligible Member.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

23

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

13.6 Assignment. This Agreement shall not be assigned, in whole or in part, by
NationsHealth [* * *], except that NationsHealth shall have the right to determine which of its
directly or indirectly owned subsidiaries or divisions shall participate as NationsHealth
Pharmacies hereunder, subject to the approval of ESI. ESI may assign this Agreement or delegate
any or all of its rights or obligations hereunder to any parent, subsidiary, or affiliated company
of ESI or to a successor company. Any permitted assignee shall assume all obligations and
liabilities of its assignor under this Agreement. This Agreement shall inure to the benefit of and
be binding upon each party and its respective successors and permitted assignees and any
corporation, partnership, individual, or person acting in a fiduciary capacity on their behalf.

13.7 Marketing, Advertisement and Reservation of Rights. ESI may use NationsHealth’s
and any NationsHealth Pharmacy’s name, location and description of services for purposes of
advertising or marketing prescription drug programs. ESI reserves the exclusive rights to, control
of and in the use of the names “Express Scripts”, “PERx” and all other names, symbols, trademarks
and service marks that have been used, are presently existing or used by or hereinafter adopted by
ESI in the future. Except as agreed to herein, neither NationsHealth nor any NationsHealth
Pharmacy shall advertise or use any names, symbols, trademarks or service marks, including the
Marks and Logos, of ESI in any advertising or promotional materials or otherwise without the prior
written consent of ESI. It is understood and agreed that any decal incorporating an ESI service
mark is solely for window or counter display by a NationsHealth Pharmacy in connection with its
performance under this Agreement. Upon termination of NationsHealth for any reason, NationsHealth
will immediately discontinue the use of any name, symbol, trademark or service mark of ESI,
including the Mark(s) and Logo(s). NationsHealth is the owner of all right, title and interest in
and to its marks and logos, including any and all goodwill associated therewith and symbolized
thereby. To effectuate the purpose of the foregoing sentences, NationsHealth as licensor hereby
grants to ESI as licensee, for the Term of this Agreement, a royalty-free, non-transferable,
terminable, non-exclusive license, expressly subject to the terms and conditions of this Agreement
to use NationsHealth’s marks and logos in accordance with NationsHealth’s graphical standards and
solely on and in connection with furthering the purposes of this Agreement. ESI shall have no right
to sublicense, assign or transfer any of the rights granted it hereunder. ESI recognizes that
NationsHealth’s marks and logos, including the associated goodwill, have great value to
NationsHealth. ESI covenants and agrees that all uses by it of NationsHealth’s marks and logos
shall inure solely to the benefit of NationsHealth and that ESI shall not acquire any right, title,
or interest in, to or under the NationsHealth marks or logos as a result of this license and/or its
use of the NationsHealth marks or logos under this license.

13.8 Proprietary Rights. Except as agreed to by the parties in writing, neither
party may utilize the service marks, trademarks, or tradenames of any the other party, or any
service marks, trademarks, or tradenames so similar as likely to cause confusion. The programs
implemented by each party will remain the sole property of such party and will only be used by the
other party pursuant to the terms of this Agreement. Further, neither party has the right to use,
reproduce or adapt any information, data, work, compilation, computer program, manual, process or
invention obtained from, provided by, or owned by the other party (or
in the case of NationsHealth, any plan Sponsor) including, but not limited to, such party’s
programs, services, business practices, procedures, and manuals, without such party’s prior written
consent.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

24

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

13.9 Force Majeure. Any party’s delay in, or failure of, performance under this
Agreement shall be excused where such delay or failure is the result of causes that are beyond the
reasonable control of the affected party, including acts of God (e.g., nature, fire, flood, etc.),
terrorism, war, civil disturbance, court order, governmental intervention, epidemic, pandemic,
failures or fluctuations in electrical power, heat, light, air conditioning, computer, software,
communications, transmission or mechanical failure, work stoppage, delays or failure to act, or
other catastrophe beyond a party’s reasonable control. In such an event, the parties will use
commercially reasonable efforts to resume performance as soon as reasonably possible under the
circumstances giving rise to the party’s failure to perform. Both ESI and NationsHealth will use
joint communication and resources to assist the other party in the event of a Force Majeure.

13.10 Headings. The article and section headings contained in this Agreement are for
convenience only and will in no manner be construed as part of this Agreement.

13.11 Governing Law. This Agreement shall be construed and governed in all respects
according to the internal laws in the State of [* * *], without regard to conflict of law
principles.

13.12 Waiver. No waiver of a breach of any covenant or condition shall be construed
to be a waiver of any subsequent breach. No act, delay or omission done, suffered, or permitted by
the parties shall be deemed to exhaust or impair any right, remedy or power of the parties
hereunder.

13.13 Severability. Should any provision of this Agreement be held or ruled
unenforceable or ineffective under the law, such a ruling will in no way affect the validity or
enforceability of any other clause or provision contained herein.

13.14 [* * *]

13.15 [* * *]

13.16 Counterparts. This Agreement may be executed in one or more counterparts, each
of which will be deemed an original and together will constitute one and the same Agreement.
Facsimile execution and delivery of this Agreement is legal, valid and binding execution and
delivery for all purposes.

13.17 Incorporation of Recitals. The recitals are hereby incorporated into and made a
part of this Agreement.

13.18 Subcontractor. The Services provided by NationsHealth (and the NationsHealth
Pharmacies, if applicable) hereunder are unique to NationsHealth and may only be performed by
NationsHealth, [* * *]. Unless otherwise agreed to in writing by the parties, NationsHealth may
not subcontract all or any portion of the Services it provides hereunder, including the fulfillment
of Medicare Part B Program Drugs and/or Supplies. In the event the parties agree in writing that
NationsHealth may subcontract Services it performs hereunder, then all subcontractors shall be
subject to the terms and conditions of this Agreement. Further, there must be a written
subcontract agreement between NationsHealth and such subcontractor and such agreement must
reference this Agreement and the subcontractor’s foregoing obligation.

13.19 No-Third-Party Beneficiary. This Agreement has been entered into solely for the
benefit of NationsHealth and ESI, and is not intended to create any legal, equitable, or beneficial
interest in any third party or to vest in any third party any interest as to enforcement or
performance.

13.20 Interpretation of Plan. NationsHealth will not name or represent that ESI is,
and ESI will not be, a Plan Administrator or fiduciary of any prescription drug benefit plan (the
“Plan”) as those terms are used in the Employee Retirement Income Security Act (“ERISA”), 29 USC Sec. 1001 et seq., and
the regulations promulgated under ERISA.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

25

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

13.21 Relationship with Plan Sponsors. [* * *]. NationsHealth further acknowledges
and agrees that it has not entered into this Agreement based upon representations by any person
other than ESI and that no person, entity or organization other than ESI shall be held accountable
or liable to NationsHealth for any of ESI’s obligations to NationsHealth created under this
Agreement. This provision shall not create any additional obligations whatsoever on the part of
ESI other than those obligations created under other provisions of this Agreement.

13.22 Compliance with Laws. With respect to performance of this Agreement, each party
shall abide by all applicable statutes, laws, rules and regulations now in effect or hereinafter
enacted, including without limitation: (a) Medicare Part B, (b) laws regarding the provision of
insurance, third party administration and primary health care services, including Medicare and
Medicaid; (c) the Prescription Drug Marketing Act; (d) the Federal Controlled Substances Act; (e)
the Federal Food, Drug and Cosmetics Act; (f) any state laws relating to the dispensing of
pharmaceutical products; (g) applicable State Board of Pharmacy regulations, and (h) laws relating
to billing or sales practices. Each party shall comply with all governmental regulations,
including all reporting and disclosure requirements, with respect to provision of the Services.

13.23 Construction. NationsHealth and ESI have each participated jointly in the
negotiation of this Agreement, and each has had the advice of legal counsel to review, comment
upon, and draft this Agreement. Accordingly, it is agreed that no rule of construction shall apply
against any party or in favor of any party, and any uncertainty or ambiguity shall not be
interpreted against any one party and in favor of the other.

13.24 [* * *]

13.25 Construction with Other Documents. In the event of any conflict between
applicable law and the terms and conditions of this Agreement, the terms and conditions of the
Provider Manual or the terms and conditions of the Operation Guide, applicable law followed by the
terms of this Agreement shall prevail. Similarly, to the extent there is a conflict between the
terms and conditions of the Provider Manual and the Operation Guide, the terms of the Operation
Guide shall prevail.

13.26 Right of First Offer. NationsHealth hereby grants to ESI a binding Right of
First Offer as set forth in Exhibit M, attached hereto and incorporated herein by this
reference. Such Right of First Offer shall remain in place until the expiration or early
termination of this Agreement by ESI.

13.27 Survival. Notwithstanding anything herein to the contrary, all provisions
intended to survive the expiration or termination of this Agreement, including Section 3.5 (c) and
(d), 3.6-3.7, 3.12, 3.15, 4.2 (c), 4.3, 5.2 (f) and (g), 7.1, 8-9, 13.2, 13.5, 13.8-13.9, 13.11 and
13.13-13.27 shall survive such expiration or termination for any reason. In addition, (a) Section
3.13 shall survive the expiration or termination of this Agreement for a period of [* * *] and (b)
upon the expiration or termination of this Agreement the provisions of Section 6.4 relating to the
ownership of intellectual property shall survive but the provisions relating to maintenance and
sharing of costs shall terminate,

[SIGNATURE PAGE FOLLOWS]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

26

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

THIS AGREEMENT CONTAINS A BINDING ARBITRATION PROVISION WHICH MAY BE ENFORCED

BY THE PARTIES

IN WITNESS WHEREOF, the parties have executed and entered into this Agreement as of the date
set forth below.

	 	 	 
	UNITED STATES PHARMACEUTICAL GROUP,

LLC dba NATIONSHEALTH, INC.

	 	EXPRESS SCRIPTS, INC.
	 
	 	 
	By:      /s/ Glenn M. Parker
	 	 /s/ Edward Ignaczak
	 

	 	 

	 

	 	[* * *],
	Printed Name:  Glenn M. Parker

	 	[* * *]
	 

	 	 
	 
	 	 
	Title:    CEO
	 	 
	 

	 	 
	 
	 	 
	Date:   12/5/08

	 	Date:   12-11-08
	 

	 	 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

27

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT A

RESERVED

REMAINDER OF PAGE LEFT INTENTIONALLY BLANK

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

A-1

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT B

MEDICARE PART B PROGRAM DRUGS

AND

MEDICARE PART B PROGRAM SUPPLIES

[* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

B-1

 

Exhibit 10.77

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT C

NATIONSHEALTH PHARMACIES

The following is a list of NationsHealth’s Pharmacies covered by this Agreement (if a location
is not listed, then such location is not contracted to participate and will not receive
reimbursement from ESI):

[* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

C-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT D

Provider Certification

	Provider is to seek completion of the Provider Certification from each Pharmacy.
GENERAL INFORMATION TODAY’S DATE
NCPDP #: INSURANCE CARRIER:
(Attach Certificate of Insurance)
(Please attach additional list of pharmacies w/ Identical Federal Tax ID) We require comprehensive general liability coverage of
OR CHAIN CODE:? $1,000,000 per occurrence/$3,000,000 annual aggregate. A copy of your
liability coverage showing these levels must be attached.
NPI #: HOURS/DAYS OF SERVICE:
LEGAL NAME: MON-FRI: A.M. P.M.
DBA NAME: SAT: A.M. —  P.M.
PHYSICAL
 _____ 
SUN: A.M. —  P.M.
ADDRESS:
City: STATE:
ZIP:  —  PHARMACIST IN CHARGE:
(Attach copy of License)
PHONE: MEDICAID #:
FAX: STATE ISSUED FROM:
FEDERAL TAX ID: MEDICAID #:
STATE ISSUED FROM:
STATE TAX ID:
STATE ISSUED FROM:
STORE FEDERAL DEA #: MEDICARE PART B #:
STORE LICENSE #:
(Attach copy of License) (Attach copy of License)
REMITTANCE ADDRESS (IF DIFFERENT FROM ABOVE) SOFTWARE VENDOR:
SWITCHING COMPANY:
ADDRESS: CONTACT PERSON:
CITY: E-MAIL (If available):
STATE, ZIP
 _____ 
Pharmacy Website:
Provider Directory Information: If you would like the store directory NOTE: It is the responsibility of the provider to notify Express Scripts
information to be listed different than above, please contact Express
 _____ 
in writing of any changes to their pharmacy information.
Scripts Network Contracting & Management at 866-296-9943.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

D-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT E

Provider Credentialing Representations and Warranties

[* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

E-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT F

Notice of New Pharmacy and

Applicability of Credentialing Representations and Warranties

[* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

F-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT G

BILLING AND REIMBURSEMENT TO NATIONSHEALTH

[* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

G-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT H

ELECTRONIC CHANNEL INFORMATION

[* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

H-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT I

ADDITIONAL PERFORMANCE STANDARDS

[* * *]

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

I-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

[* * *]

[* * *]

[* * *]

REMAINDER OF PAGE LEFT INTENTIONALLY BLANK

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

I-1-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT J

BUSINESS ASSOCIATE AGREEMENT

[* * *]

REMAINDER OF PAGE LEFT INTENTIONALLY BLANK

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

J-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT K

NATIONSHEALTH’S CODE OF CONDUCT

[* * *]

REMAINDER OF PAGE LEFT INTENTIONALLY BLANK

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

K-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT L

LICENSED MARK AND LOGO OF ESI

[* * *]

REMAINDER OF PAGE LEFT INTENTIONALLY BLANK

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

L-1

 

EXECUTION ORIGINAL

This document contains Express Scripts, Inc. proprietary information and/or data. Recipient, by
accepting this document, agrees that it will not duplicate, use, or disclose-in whole or in
part-this document, or the information contained therein, or any part thereof to others for any
other purpose except as specifically authorized in writing by Express Scripts, Inc. EXEMPT FROM
PUBLIC DISCLOSURE: Information contained herein is confidential information of Express Scripts,
Inc. and is exempt from public disclosure under 5 U.S.C. §552 (b). Do not disclose outside of the
recipient organization of the United States Government.

EXHIBIT M

RIGHT TO NOTICE OF OFFER

The parties agree as follows:

1. NationsHealth specifically agrees that within [* * *] of receiving a written offer (a
“Written Offer”) to consummate a transaction (as defined in Section 3 of this Exhibit M),
it shall provide a written summary of the material economic and other pertinent material terms of
such Written Offer (the “Written Offer Summary”) to ESI. ESI shall have seven calendar days (the
“Seven Day Review Period”) to review the Written Offer Summary. Until the earlier of the
conclusion of the Seven Day Review Period or the date that ESI notifies NationsHealth that it is
not interested in consummating a Transaction on similar or better terms than those contained in the
Written Offer Summary, NationsHealth shall not consummate a transaction or enter into exclusivity
with an interested purchaser. For purposes of clarification, NationsHealth shall have no
obligation to ESI under this Right to Notice of Offer after the conclusion of the Seven Day Review
Period.

2. [* * *]

3. For purposes of this Exhibit M, “Transaction” shall mean (i) the sale of all or
substantially all of the assets of NationsHealth, (ii) the sale or transfer of a majority of the
outstanding voting securities of NationsHealth, or (iii) [* * *].

4. [* * *]

5. Notwithstanding anything herein or in the Agreement, in the event it becomes apparent that
NationsHealth will complete or it completes a Transaction with any entity that ESI determines to be
a competitor of ESI’s, then ESI may terminate this Agreement upon seven (7) days’ advance written
notice to NationsHealth and NationsHealth shall cooperate with ESI in transitioning ESI Members to
other providers.

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

			
	 	 	 
	Copyright © 2007 Express Scripts, Inc.
	 	Confidential and Proprietary
	All rights reserved.	 	 
	Medicare Part B Agreement	 	 

 

M-1Exhibit 10.78

Exhibit 10.78

EXECUTION COPY

SETTLEMENT AGREEMENT AND GENERAL RELEASE

This SETTLEMENT AGREEMENT AND GENERAL RELEASE (the “AGREEMENT”) is made and entered into this
16th day of April, 2009, by and between NATIONSHEALTH, INC. (“NATIONSHEALTH”) and UNITED STATES
PHARMACEUTICAL GROUP, L.L.C. (“USPG”) (collectively referred to herein as the “COMPANY”), on the
one hand, and SUSAN HILL (“MS. HILL”) and ROBERT HILL (“MR. HILL”) (collectively referred to as
“the HILLS”), on the other hand (the HILLS and the COMPANY are collectively referred to herein as
the “PARTIES”), and is joined, solely as to Section 4(b) hereof, by CAPITALSOURCE FINANCE LLC in
its capacity as Agent for the Lenders under the Loan Agreement referred to below (“Agent”).

WHEREAS, USPG and MS. HILL entered into a Stock Purchase Agreement, dated September 4, 2007,
that provides for USPG to purchase one hundred percent (100%) of the stock of Diabetes Care and
Education, Inc. (“DCE”) (the “Purchase Agreement”);

WHEREAS, in conjunction with the purchase of DCE, NATIONSHEALTH and MS. HILL entered into an
employment agreement dated September 4, 2007 that provided for employment by MS. HILL by
NATIONSHEALTH (the “Employment Agreement”);

WHEREAS, in conjunction with the purchase of DCE, NATIONSHEALTH and MR. HILL entered into a
non-competition agreement dated September 4, 2007 that provided, among other things, certain
non-disclosure, non-competition and non-disparagement provisions by MR. HILL and the NATIONSHEALTH
(the “Mr. Hill Non-Competition Agreement”);

WHEREAS, following the closing of the Purchase Agreement, NATIONSHEALTH has employed MS. HILL
and MR. HILL in positions with responsibilities related to the ongoing management of DCE;

WHEREAS, the PARTIES have had disputes regarding the appropriate management of DCE and their
respective obligations under the Purchase Agreement and the Employment Agreement;

WHEREAS, the PARTIES have reached an agreement to compromise and settle all disputes between
them;

WHEREAS, MS. HILL has agreed that any special distribution payments as defined in Paragraph 4
of this Agreement shall be subject to the Subordination Agreement dated September 4, 2007 (the
“Subordination Agreement”) entered into between MS. HILL and CapitalSource Finance LLC (together
with its successors and assigns, “Lender” and sometimes, individually or collectively with Agent,
“CSF”) pursuant to which MS. HILL subordinated the Subordinated Debt (as defined in the
Subordination Agreement) to the Senior Debt (as defined in the Subordination Agreement);

 

 

 

WHEREAS, Lender has designated Agent as its agent to take certain actions under the Loan
Agreement (as defined in the Subordination Agreement) pursuant to Section 12.12. of the Loan
Agreement;

NOW, THEREFORE, for and in consideration of the mutual promises herein contained, and for good
and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged,
the PARTIES agree as follows:

1. The HILLS agree that they both will: (a) resign from their positions with the COMPANY
effective October 2, 2008 (the “Separation Date”), such that their last day on salary as active
employees shall be October 1, 2008 and their last day as participants in the group medical plan as
active employees shall be November 30, 2008; (b) refrain from applying for or otherwise seeking
employment with the COMPANY or any of its subsidiaries or affiliates at any time in the future; (c)
return all property of the COMPANY, including, but not limited to, access keys or cards, cell
phones, laptop computers, printers, answering machines, modems, manuals, calculators, handbooks,
files, papers, memoranda, letters, facsimiles, computer software and financial data.

2. The COMPANY shall provide to MR. HILL: (a) payment of severance at an annual rate of
$100,000.00 for a period of six (6) months (the “MR. HILL Severance”), starting on October 2, 2008
and running through and including April 2, 2009 (the “Severance Period”); and (b) reimbursement of
cost of the premiums under COBRA, following submission of appropriate documentation, for continued
medical coverage (at the same level coverage in place on October 1, 2008) for the months of
December through June 2009, provided that such payments shall cease at any such earlier time should
MR. HILL no longer be eligible for coverage under COBRA (collectively, “MR. HILL’s Separation
Benefits”). The amount set forth in Paragraph 2(a), less applicable taxes, withholdings, and
authorized deductions, will be paid to Employee in 12 equal installments with the COMPANY’s
regular, semi-monthly payroll. Each installment will be in the gross amount of $4,166.67, less
applicable taxes, withholdings, and authorized deductions. In addition to the MR. HILL Severance,
the Company shall provide to MR. HILL equal installments of $4,166.77 with the COMPANY’s regular,
semi-monthly payroll for the period April 3, 2009 through and including the date of the payment
described below in Section 4(a)(i), which “MR. HILL Additional Severance” shall be subject to
applicable taxes, withholdings and authorized deductions.

3. The COMPANY shall provide to MS. HILL: (a) payment of severance at an annual rate of
$180,000.00 for a period of six (6) months (the “MS. HILL Severance”), which shall be payable
during the Severance Period; and (b) reimbursement of cost of the premiums under COBRA, following
submission of appropriate documentation, for continued medical coverage (at the same level coverage
in place on October 1, 2008) for the months of December 2008 through June 2009, provided that such
payments shall cease at any such earlier time should MS. HILL no longer be eligible for coverage
under COBRA (collectively, “MS. HILL’s Separation Benefits”). The amount set forth in Paragraph
3(a), less applicable taxes, withholdings, and authorized deductions, will be paid to Employee in
12 equal installments with the COMPANY’s regular, semi-monthly payroll. In addition to the MS.
HILL Severance, the Company shall provide to MS. HILL equal installments of $7,500.00 with the
COMPANY’s
regular, semi-monthly payroll for the period April 3, 2009 through and including the date of
the payment described below in Section 4(a)(i) through and including the date of the payment
described below in Section 4(a)(i), which “MS. HILL Additional Severance” shall be subject to
applicable taxes, withholdings and authorized deductions. (The MS. HILL Additional Severance and
the MR. HILL Additional Severance shall collectively be known as the “Additional Severance.”)
Furthermore, the Company shall pay to MS. HILL the amount of her attorneys’ fees associated with
the negotiation of this AGREEMENT, up to a ten thousand dollar ($10,000) cap, upon submission to
the Company of documentation of such legal fees and costs.

 

 

 

4. (a) In addition to MS. HILL’s Separation Benefits described above and in lieu of any
“Earn-Out Payments” as provided for under the Purchase Agreement, the COMPANY and MS. HILL have
agreed that the COMPANY will provide her with a special distribution in the total amount of one
million seven hundred fifty thousand dollars ($1,750,000.00) (the “Special Distribution Payments”),
which shall be paid in accordance with the following schedule: (i) a three hundred thousand dollar
($300,000) payment to MS. HILL on or before June 30, 2009; (ii) a three hundred thousand dollar
($300,000) payment to MS. HILL on or before December 31, 2009; (iii) a three hundred thousand
dollar ($300,000) payment to MS. HILL on or before June 30, 2010; (iv) a four hundred thousand
dollar ($400,000) payment on or before December 31, 2010; and (v) a four hundred fifty thousand
dollar ($450,000) payment on or before June 30, 2011. Each Special Distribution Payment shall be
wire transferred by the COMPANY to the HILL’s bank account listed on Schedule 1, or such other
account as the HILLS may designate in writing to USPG from time to time. Notwithstanding the
foregoing, the lump-sum payment to be made under Section 4(a)(i) shall be reduced by the amount
that is equivalent to seventy-seven percent (77%) of the Additional Severance paid to the HILLS
under Paragraphs 2 and 3 of this AGREEMENT.

(b) The PARTIES agree that the payment of any Special Distribution Payment shall be subject
to the provisions of the Subordination Agreement. The PARTIES and Agent on behalf of Lender agree
that the Subordination Agreement shall be amended as follows:

(i) The defined terms “Earn-Out Obligation” and “Subordinated Debt” are amended so that all
references thereto in the Subordination Agreement shall, as the context requires, mean and refer to
the Special Distribution Payments.

(ii) The defined term “SPA” is amended so that all references thereto in the Subordination
Agreement shall, as the context requires, mean and refer to, and include, this AGREEMENT.

(iii) The second sentence of Section 2 of the Subordination Agreement is amended as follows:

Borrower may request to make a regularly scheduled payment of Subordinated Debt by delivering
a written notice to Senior Lender of its intent to make such a payment (a “Payment Request”) at
least six (6) weeks prior to making such payment, which request shall contain (i) a statement as to
the amount of the Special Distribution Payment to be paid and (ii) a certification from an
authorized officer of Borrower that there then exists no Default or Event of Default, and no such
Default or Event of Default would result by or from
such payment and that such payment will be made in compliance with the provisions of the SPA
as in effect as of the date hereof (except for the date of such payment).

 

 

 

(iv) The third sentence of Section 2 of the Subordination Agreement is amended as follows:

Following Borrower’s delivery of a Payment Request, Borrower may make such requested payment
of the Subordinated Debt upon its receipt of Senior Lender’s written consent thereto (a “Senior
Lender Consent”), which Senior Lender Consent shall be delivered to Borrower within six (6) weeks
of Senior Lender’s receipt of the Payment Request so long as no Default or Event of Default has
occurred and is continuing, and no such Default or Event of Default would result by or from such
payment.

The PARTIES and CSF agree that, except as otherwise provided in this AGREEMENT, the Subordination
Agreement remains in full force and effect and has not otherwise been amended or modified in any
respect, it being the intention of the PARTIES and CSF that this Section 4(b) and the Subordination
Agreement be read, construed and interpreted as one and the same instrument. The PARTIES and CSF
agree that, in the event of any conflict or inconsistency between the provisions of this AGREEMENT
and the Subordination Agreement, the terms of the Subordination Agreement shall govern with the
Special Distribution Payments being Subordinated Debt thereunder.

(c) The COMPANY shall deliver each Payment Request to Senior Lender on or before six (6) weeks
before each Special Distribution Payment is due.

(d) The COMPANY shall provide the HILLS with a copy of the Payment Request (contemporaneously
with the sending of the Payment Request, provided that inadvertent failure to provide copy thereof
to the HILLS shall not be a material breach of this AGREEMENT) and the Senior Lender Consent (per
the Subordination Agreement) with respect to such Special Distribution Payment on the date such
payment is made. The HILLS acknowledge and agree that the failure of the COMPANY to provide a copy
of the Payment Request or the Senior Lender Consent shall not affect any of CSF’s rights under the
Subordination Agreement or the subordination of the Subordinated Debt.

5. MS. HILL owns 473,933 shares of NATIONSHEALTH common stock which was issued in connection
with the Purchase Agreement. It is the intention of the signatories hereto that all such stock (the
“Shares”) shall be transferred to the COMPANY. Specifically, simultaneous with the Effective Date
of this AGREEMENT (as defined in Paragraph 15), MS. HILL shall deliver to counsel for the COMPANY
all stock certificates representing all of the Shares, duly-endorsed to transfer all such Shares to
the COMPANY, which delivery process shall include MS. HILL executing the stock power documents
appended at Appendix A. Further, MS. HILL represents and warrants that, as of the Effective Date
of this AGREEMENT: (i) she owns all rights, title and interest in and to the Shares, (ii) she has
not sold, transferred, assigned, pledged, hypothecated to any third party or otherwise encumbered
any interest in the Shares, (iii) there is no litigation or governmental proceeding or
investigation pending or, to the knowledge of MS. HILL, threatened against her, which may call into
question her ability to transfer all of the Shares to NATIONSHEALTH in accordance with this Section
5, and (iv) the
transfer by MS. HILL of the Shares to NATIONSHEALTH in accordance with this Section 5 will
result in NATIONSHEALTH owning the Shares free and clear of all encumbrances and with marketable
title. The signatories will execute all such further required documents and take all other steps
as shall be necessary to effectuate promptly at such time the transfers of the Shares, as well as
to effectuate the amendment of any corporate documentation necessary to effectuate the removal of
any rights that MS. HILL might have as a stockholder of NATIONSHEALTH. The grant of stock options
to MS. HILL on September 4, 2007 by the COMPANY shall be afforded the treatment set forth in the
applicable stock option agreement, such that Ms. Hill shall have three months from her separation
from the COMPANY to exercise the stock options, which options shall expire at such time if they
remain unexercised.

 

 

 

6. In exchange for the consideration that the HILLS will receive under this AGREEMENT, the
HILLS, on behalf of themselves, their heirs, spouses, successors, current and former agents,
representatives, attorneys, assigns, executors, beneficiaries, and administrators, hereby release
and forever discharge the COMPANY and each and all of its current and former parents, divisions,
subsidiaries (including, but not limited to, Diabetes Care and Education, Inc.), affiliates,
investors, lenders, predecessors, successors, assigns, officers, directors, attorneys,
shareholders, agents, representatives and employees (collectively, the “COMPANY RELEASED PARTIES”)
from any and all charges, complaints, claims, liabilities, obligations, promises, agreements,
damages, actions, causes of action, whether accrued or to be accrued, suits, rights, demands,
costs, losses, debts and expenses (including, but not limited to, any attorneys’ fees incurred by
the HILLS) of any nature whatsoever, whether in law or in equity, whether known or unknown, which
the HILLS now have or ever may have had against the COMPANY RELEASED PARTIES, up to the date of
this AGREEMENT including, but not limited to, any and all matters related in any way to the HILLS’
employment with or resignation from the COMPANY, the Purchase Agreement, the Employment Agreement,
as well as all claims under Title VII of the Civil Rights Act of 1964, the Americans with
Disabilities Act, the Age Discrimination in Employment Act (including the Older Workers Benefit
Protection Act), the Employee Retirement Income Security Act of 1974, the Family and Medical Leave
Act, Kentucky Civil Rights Act (Ky. Rev. Stat. § 344.010, et. seq.), Kentucky’s 1976 Equal
Employment Opportunities Act (Ky. Rev. Stat. § 207.130, et. seq.), Kentucky’s Equal Pay Law (Ky.
Rev. Stat. § 337.420, et. seq.), any other federal, state or local anti-discrimination, wage or
employment-related laws and any other contractual or tort claims related in any way to the HILLS’
employment with or resignation from the COMPANY, any other claims in any way related to the Shares
and any other claims for compensation, benefits or equity. Notwithstanding this foregoing, nothing
in this AGREEMENT shall relieve the COMPANY of any indemnification obligations that would otherwise
exist for the HILLS in their capacity as former directors and officers of the COMPANY with respect
to claims or investigations involving the activities of DCE or the COMPANY.

7. In exchange for the consideration that the COMPANY will receive under this AGREEMENT, the
COMPANY, on behalf of its current and former parents, divisions, subsidiaries (including, but not
limited to, Diabetes Care and Education, Inc.), affiliates, predecessors, successors, assigns,
officers, directors, attorneys, shareholders, agents, representatives and employees hereby release
and forever discharge the HILLS on behalf of
themselves, their heirs,
spouses, successors, current and former agents, representatives, attorneys, assigns, executors,
beneficiaries, and administrators, (collectively, the “HILLS
RELEASED PARTIES”) from any and all charges, complaints, claims, liabilities, obligations,
promises, agreements, damages, actions, causes of action, whether accrued or to be accrued, suits,
rights, demands, costs, losses, debts and expenses (including, but not limited to, any attorneys’
fees incurred by the COMPANY) of any nature whatsoever, whether in law or in equity, whether known
or unknown, which the COMPANY now has or ever may have had against the HILLS RELEASED PARTIES, up
to the date of this AGREEMENT, including, but not limited to, any and all matters related in any
way to the HILLS’ employment with the COMPANY, the Purchase Agreement, and the Employment
Agreement. Notwithstanding the provisions of this Section 7, nothing contained in this Section 7
shall release or otherwise prevent or impair a claim preserved under Section 8 below.

 

 

 

8. (a) In further exchange for the consideration that the HILLS will receive under this
AGREEMENT, (i) MS. HILL agrees that the Covenant Not to Compete contained in Section 6(f) of the
Employment Agreement will remain in full force and effect for a period of three (3) years following
the Separation Date. Furthermore, MS. HILL agrees that the non-disclosure and intellectual
property protection obligations contained in Section 6(a)-(d) of the Employment Agreement will
remain in full force and effect; (ii) MR. HILL agrees that the Covenant Not to Compete contained in
Section 1(f) of the Non-Competition Agreement will remain in full force and effect for a period of
three (3) years following the Separation Date; and (iii) MS. HILL agrees that the obligations under
Articles 4 (Representations and Warranties Concerning the Company), 6.4 (Confidentiality), 6.5
(Covenant Not to Compete or Solicit), 8.2 (Indemnification Provisions for Buyer’s Benefit), except
that a breach of Article II of the Purchase Agreement shall no longer form the basis of any claim,
8.3 (Indemnification Provisions for Seller’s Benefit), 8.4 (Matters Involving Third Parties), 8.7
(Reduction for Insurance and Third Party Payments and 8.8 (Limits on Remedies) under the Purchase
Agreement will remain in full force and effect. Furthermore, MR. HILL agrees that the
non-disclosure, intellectual property protection and other obligations contained in Section
1(b)-(e) and (g-i) of the Non-Competition Agreement will remain in full force and effect.

(b) The HILLS warrant, represent and acknowledge that they know of no matters, information or
concerns of any type regarding the COMPANY’s actions, policies, practices and procedures,
particularly any concerns regarding regulatory compliance. The HILLS affirmatively warrant,
represents and acknowledge that their execution of this Agreement reflects the fact that each of
MS. HILL and MR. HILL are not aware of any matter, information or concern that could have, or
should have, been disclosed as of the date and time of execution of this Agreement. The HILLS
further warrant, represent and acknowledge that each has not been prevented, prohibited or in any
manner restricted by the COMPANY from making a full disclosure to the COMPANY of any and all of
regulatory concerns.

9. The PARTIES agree to describe the circumstances of the HILLS’ departure from the COMPANY in
accordance with Appendix B.

 

 

 

10. The PARTIES agree that they and their agents will not publicize or disclose, directly or
indirectly, the terms, conditions or existence of this AGREEMENT to anyone other than their
attorneys, physicians, accountants, and financial advisors. The PARTIES further agree that they
will advise any individual to whom the terms, conditions or existence of this AGREEMENT have been
disclosed (the “RECIPIENTS”) of the confidentiality requirements of
this paragraph, will secure the agreement of all RECIPIENTS to abide by such confidentiality
requirements, and will use their best efforts to ensure that the confidentiality requirements are
complied with in all respects. The HILLS further agree that they will not appropriate for their
own use, disclose to any third party, or authorize anyone else to disclose, unless authorized by
the President of the COMPANY in writing, any confidential information concerning matters related to
the COMPANY’s business. For purposes of this subsection, the term “Confidential Information” means
nonpublic information and proprietary information, including trade secrets, sales reports, account
files, customer names, customer lists, management or strategic plans, methods of doing business,
contact lists, identities of vendors and contractors, pricing information, marketing strategies and
literature, employee handbooks or manuals, internal self-critical studies or analyses performed by
the COMPANY, information regarding the COMPANY’s personnel polices or actions taken, any document
which indicates by title or substance that it was prepared, generated or distributed by or on
behalf of the COMPANY, any other document or material reflecting internal information about the
COMPANY that is not readily available to the general public regarding the COMPANY’s operations or
policies, or any documents or information relating to any of the above.

11. This AGREEMENT shall not be construed as an admission of any sort by either of the
PARTIES, nor shall it be used as evidence in a proceeding of any kind, except one in which one of
the PARTIES alleges breach of the terms of this AGREEMENT or one in which one of the PARTIES elects
to use this AGREEMENT as a defense to any claim barred by the AGREEMENT.

12. The HILLS agree that they will not, directly or indirectly, make or allow or cause others
to make, whether in oral, print, electronic or other form, any statement or take any action that
reasonably could be construed to be a false, derogatory, disparaging, or misleading statement of
fact or a libelous or slanderous statement of or concerning: (a) the COMPANY or any of its current
and former parents, divisions, subsidiaries (including, but not limited to, Diabetes Care and
Education, Inc.), affiliates, predecessors, successors, assigns, officers, directors, attorneys,
shareholders, agents, representatives or employees; or (b) any product designed, produced, or sold
by the COMPANY.

13. The COMPANY agrees that it will not, directly or indirectly, make or allow or cause others
(including employees) to make, whether in oral, print, electronic or other form, any statement or
take any action that reasonably could be construed to be a false, derogatory, disparaging, or
misleading statement of fact or a libelous or slanderous statement of or concerning the HILLS.

14. By signing this AGREEMENT, the HILLS acknowledge and agrees that: (a) they have been
afforded a reasonable and sufficient period of time of not less than twenty-one (21) days for
deliberation thereon and for negotiation of the terms thereof; (b) they have carefully read and
understand the terms of this AGREEMENT; (c) have signed this AGREEMENT freely and voluntarily and
without duress or coercion and with full knowledge of its significance and consequences and of the
rights relinquished, surrendered, released and discharged hereunder; (d) the only consideration for
signing this AGREEMENT are the terms stated herein and no other promise, agreement or
representation of any kind has been made to them by any person or entity whatsoever to cause them
to sign this AGREEMENT; and (e) they were apprised by the
COMPANY of their right to consult with legal counsel or a representative of their choice and
they did so consult with legal counsel before signing this AGREEMENT.

 

 

 

15. The release of ADEA claims set forth in Paragraph 6 of this AGREEMENT Release may be
revoked, in a writing sent to counsel for the COMPANY, Terri Chase, McDermott Will & Emery LLP, 340
Madison Avenue, New York, New York 10173 at any time during the period of seven (7) calendar days
following the date of execution by the HILLS. If such seven (7) day revocation period expires
without either of the HILLS exercising his or her revocation right, the obligations of this
AGREEMENT then will become fully effective (the “Effective Date”).

16. (a) The HILLS agree to make themselves reasonably available to respond to inquiries from
the COMPANY for six months following the Separation Date. The HILLS also agree to cooperate with
and assist the COMPANY, at its request, in connection with any claim or litigation arising out of
events occurring or agreements made, during the course of their employment with DCE or the COMPANY.
The HILLS acknowledge and agree that this promise to cooperate as set forth in this section is a
material term under this AGREEMENT. Further, upon service on either of the HILLS, or anyone acting
on their behalf, of any order or other legal process requiring either of the HILLS to divulge
information prohibited from disclosure under this AGREEMENT, the HILLS shall immediately, but in
any event no later then within two business days, notify Joshua Weingard, or his successor, of such
service and of the content of any testimony or information to be provided pursuant to such order or
process and the HILLS shall cooperate with the COMPANY in any lawful efforts to avoid such
disclosure.

(b) The COMPANY agrees to reimburse or indemnify the HILLS for any out-of-pocket expenses,
including but not limited to travel expenses, incurred in fulfilling their duties under Paragraph
16(a) of this AGREEMENT.

17. The HILLS agree that if it is found by a court of law that either MR. HILL or MS. HILL has
violated any of their obligations under Paragraphs 8(a) or 10 of this AGREEMENT, they shall return
to the COMPANY the Separation Benefits and Special Distribution Payments provided for under
Paragraphs 2-4 of this AGREEMENT, and they shall indemnify the COMPANY from and against any and all
judgments, damages, losses, liabilities, attorneys’ fees, costs and other expenses incurred as a
result of the HILLS’ violation(s). The COMPANY agrees that if it pursues an action under this
paragraph and it is found by a court of law that neither MR. HILL nor MS. HILL has violated any of
their obligations under Paragraphs 8(a) or 10 of this AGREEMENT, the COMPANY shall indemnify the
HILLS for all attorneys’ fees, costs and other expenses incurred as a result of defending such
action.

18. The COMPANY agrees that, if it is determined by a court of law that the COMPANY breached a
provision of this AGREEMENT, then the COMPANY will indemnify the HILLS for all attorneys’ fees,
costs and other expenses incurred as a result of the COMPANY’S breach of any provision of this
AGREEMENT or in any successful action by the HILLS to enforce any provision of this AGREEMENT,
including but not limited to an action to enforce the Special Distribution Payments as provided in
Paragraph 4 of this AGREEMENT.

 

 

 

19. This AGREEMENT represents the entire agreement between the PARTIES with respect to the
subject matters addressed herein and supercedes all prior agreements between the PARTIES, whether
written or oral, except as set forth in Paragraph 8 of this AGREEMENT. This AGREEMENT may not be
altered or amended, except in a written document executed by the PARTIES, which document
specifically references this AGREEMENT. Should the HILLS seek to challenge the validity of this
AGREEMENT or any provision thereof (except the HILLS’ release and waiver of claims and rights under
ADEA), the HILLS shall, as a pre-condition, return to the COMPANY the Separation Benefits and
Special Distribution Payments provided for in Paragraphs 2-4 of this AGREEMENT. Further, if either
of the HILLS assert claims against the COMPANY that are released by this AGREEMENT, the COMPANY
shall be entitled to repayment of the Separation Benefits and Special Distribution Payments
provided for in Paragraphs 2-4 of this AGREEMENT, as well as its attorneys’ fees and costs in
obtaining repayment of these sums and a dismissal of any claims filed against the COMPANY that are
released by this AGREEMENT. Upon execution of this Agreement, MS. HILL expressly agrees that she
is not entitled to any of the “Earn-Out Payments” further described in Section 2.6 of the Purchase
Agreement.

20. The PARTIES agree that a failure by any party at any time to require performance of any
provision of this AGREEMENT shall not waive, affect, diminish, obviate or void in any way that
party’s full right or ability to require performance of the same, or any other provisions of this
AGREEMENT, at any time thereafter.

21. The terms of this AGREEMENT are the result of negotiations between the PARTIES and there
shall be no presumption that any ambiguities in the AGREEMENT should be resolved against any party
to this AGREEMENT. Any controversy concerning the construction of this AGREEMENT should be decided
neutrally in light of conciliatory purposes, and without regard to authorship.

22. This AGREEMENT shall be deemed entered into and executed in the State of Florida and shall
be interpreted, enforced and governed under the laws of the State of Florida. Any recourse for any
alleged violation of any provision of this AGREEMENT shall be addressed exclusively through an
action for breach of contract in any of (i) the courts of Broward County, Florida, (ii) the U.S.
District Court located in Broward County, Florida, (iii) the courts of Jefferson County, Kentucky,
or (iv) the U.S. District Court located in Jefferson County, Kentucky (collectively, the
“Designated Courts”), and hereby irrevocably accept the exclusive personal jurisdiction of those
courts for the purposes of any suit, action, or proceeding. In addition, the HILLS, USPG and the
COMPANY hereby irrevocably waive, to the fullest extent permitted by law, any objection which the
HILLS or the COMPANY may now or hereafter have to the laying of venue of any suit, action, or
proceeding arising out of or relating to this AGREEMENT or any judgment entered by any court in
respect thereof in the Designated Courts, and hereby further irrevocably waive any claim that any
suit, action, or proceeding brought in any such court has been brought in an inconvenient forum.

23. The PARTIES warrant and represent that they have read and understand the foregoing
provisions of this AGREEMENT and that they and their respective signatories are fully authorized
and competent to execute this AGREEMENT on their behalf. The HILLS
further warrant and represent that neither of them have previously assigned or transferred any
claims that are the subject of the release contained in Paragraph 6 herein.

24. This AGREEMENT may be signed in counterparts and transmitted by facsimile or electronic
copies. A facsimile or electronic signature shall be deemed as effective as an original.

 

 

 

Executed as an agreement effective as of the provisions of Paragraph 15 of this AGREEMENT.

NATIONSHEALTH, INC.

	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Timothy Fairbanks
	 	 	 	April 16, 2009
	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Date	 	 
	 
	 	 	 	 	 	 	 	 
	UNITED STATES PHARMACEUTICAL GROUP, LLC (“USPG”)	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Timothy Fairbanks
	 	 	 	April 16, 2009	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Date	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Susan Hill
	 	 	 	April 16, 2009	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	Susan Hill
	 	 	 	Date	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Robert Hill
	 	 	 	April 16, 2009	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	Robert Hill
	 	 	 	Date	 	 
	 
	 	 	 	 	 	 	 	 
	Solely as to Section 4(b) above:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	CAPITALSOURCE FINANCE LLC, AS AGENT	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Natasha Luddington
	 	 	 	April 16, 2009	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}]]